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ABSTRACT 
 
2-(2-Methoxyphenoxy)pyrimidine (37), 2-(4-methoxyphenoxy)pyrimidine (39), 
2-phenoxypyrimidine (41), 2-(3-methoxyphenoxy)pyrimidine (43), 2-(o-
tolyloxy)pyrimidine (45), 2-(pyrimidin-2-yloxy)phenol (47), 2-(3-
nitrophenoxy)pyrimidine (49) and 2-(p-tolyloxy)pyrimidine (51) were prepared by 
reacting 2-chloropyrimidine (35) with o-methoxyphenol, p-methoxyphenol, phenol, m-
methoxyphenol, o-cresol, 1,2-dihydroxybenzene, m-nitrophenol and p-cresol 
respectively. Reactions of 2-chloropyrimidin-4-amine (52) with phenol produced 2-
phenoxypyrimidin-4-amine (53), while reactions of 2-chloropyrazine (54) with o-
methoxyphenol and p-methoxyphenol yielded 2-(2-methoxyphenoxy)pyrazine (55) and 
2-(4-methoxyphenoxy)pyrazine (56) respectively. The structures of these compounds 
were confirmed using 
1
H NMR, 
13
C NMR, IR and GC-MS spectra. The fluorescence 
properties were recorded using Luminescence Spectrophotometer. All 
phenoxypyrimidines and phenoxypyrazines showed fluorescence properties in various 
solvents. Phenoxypyrimidines showed higher fluorescence intensity than 
phenoxypyrazines.   
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ABSTRAK 
 
2-(2-Metoksifenoksi)pirimidina (37), 2-(4-metoksifenoksi)pirimidina (39), 2-
fenoksipirimidina (41), 2-(3-metoksifenoksi)pirimidina (43), 2-(o-
metilfenoksi)pirimidina (45), 2-(2-hidroksifenoksi)pirimidina (47), 2-(3-
nitrofenoksi)pirimidina (49) dan 2-(p-metilfenoksi)pirimidina (51) disediakan melalui 
tindak balas 2-kloropirimidina (35) masing-masing dengan o-metoksifenol, p-
metoksifenol, fenol, m-metoksifenol, o-kresol, 1,2-dihidroksibenzena, m-nitrofenol dan 
p-kresol. Tindak balas 2-kloropirimidin-4-amina (52) dengan fenol menghasilkan 2-
fenoksipirimidin-4-amina (53), manakala tindak balas 2-kloropirazina (54) dengan o-
metoksifenol dan p-metoksifenol masing-masing menghasilkan 2-(2-
metoksifenol)pirazina (55) dan 2-(4-metoksifenoksi)pirazina (56). Struktur semua 
sebatian ditentukan dengan menggunakan spektroskopi RMN 
1
H dan 
13
C, IM dan KG-
SJ. Ciri pendafluoran telah direkodkan menggunakan Spektrofotometer Pendaran. 
Semua terbitan-terbitan fenoksipirimidina dan fenoksipirazina menunjukkan sifat-sifat 
pendafluoran di dalam pelbagai jenis pelarut organik. Terbitan fenoksipirimidina 
menunjukkan keamatan pendafluoran yang lebih tinggi daripada terbitan 
fenoksipirazina. 
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1CHAPTER 1: INTRODUCTION
1.1 Diazines
Heterocyclic compounds are organic compounds containing at least one atom of
carbon and at least one element other than carbon such as sulphur, oxygen or nitrogen
within a ring structure. The stem ‘-cyclic’ implies a ring structure, whereas ‘hetero’
refers to an atom other than carbon. Many heterocyclic compounds are carcinogenic.
Among the heterocyclic compounds, there are aromatic (e.g. pyridine) and nonaromatic
(e.g. tetrahydrofuran).1
Heterocyclic compounds can be divided into heteroaromatic and heteroalicyclic
types. The chemistry of the heteroalicyclic compounds in general is similar to that of
their aliphatic analogous, but that heteroaromatic compounds involve additional
principles. Aromatic compounds possess rings in which each of the rings atoms is in the
same plane and a p-orbital perpendicular to the ring plane.2
This research was focused on six-membered ring compounds with two
heteroatoms, i.e pyrimidine and pyrazine or also known as diazine.  Pyrimidines and
pyrazines are stable, colourless compound which are soluble in water. The two parent
heterocycles, unlike pyridine are expensive and not readily available and so are seldom
used as starting materials for the synthesis of their derivatives.3
In diazines, the heteroatoms withdraw electron density from the ring carbons
even more than in pyridine, so the unsubsituted diazines are even more resistant to
electrophilic substitution than pyridine. This increased electron deficiency at carbon
atom makes the diazines more easily attacked by nucleophiles than pyridines. The
availability of nitrogen lone pair is also reduced: each of the diazines is appreciably less
2basic than pyridine, reflecting the destabilizing influence of the second nitrogen on the
N-protocation.
Nevertheless, diazines form salts and react with alkyl halides and with peracids
to give N-alkyl quaternary salts and N-oxides, respectively. In general, electrophilic
additions take place at one nitrogen only, because the presence of the positive charge
renders the second nitrogen extremely unreactive towards a second electrophilic
addition. A very characteristic feature of diazine chemistry is associated with their
strongly electron-poor nature, therefore they add nucleophilic reagents easily. Without
halide to be displaced, such adducts require an oxidation to complete an overall
substituton. However, halo-diazines where the halide is α or γ to a nitrogen, undergo
very easy nucleophilic displacements, the intermediates being particularly well
stabilized.3 Figure 1.1 shows the typical reactions of diazine illustrated with pyrimidine.
N
N
N
NH
N
N
N
N
N
N
RH
RLi
+ H+
MeI
RCO3H
nucleophilic
substitution
of hydrogen
alpha to
nitrogen requires
of dihydro-adduct
H Me
O
easy electrophilic addition at
nitrogen produces pyrimidinium salts
pyrimidine N -oxide
E electrophilic substitutionsdo not occur (unless
activating amino or oxygen
substituents are
present)
Figure 1.1: Typical reactions of diazine illustrated by pyrimidine
3The nucleophilic displacement of halogen and other leaving group by ‘soft’
nucleophiles i.e amines, thiols, alkoxides and enolates is a very important method for
manipulation of diazines. Only 5-halopyrimidines, in analogy to 3-halopyridines, are
relatively resistant. Figure 1.2 shows the order of reactivity in nucleophilic
displacements of leaving groups3.
Figure 1.2: The order of reactivity in nucleophilic displacements of leaving
groups
Chlorine is the most common leaving group but sulfonates are also useful and
even methoxy can be displaced in these highly reactive systems as shown in Scheme 1.1
and Scheme 1.2.
Scheme 1.1: Typical nucleophilic displacement of chlorine
Scheme 1.2: Sulfone and methoxy act as good leaving groups
4An important point to remember is that the presence on the ring of an electron-
donating group, particularly an amino group, will greatly increase or decrease the
reactivity of a halide. Although this means that clean mono-substitution in dihalo
compounds is easy, special methods may be necessary to achieve displacement of the
second halide, such as the use of ‘supernucleophiles’. Hydroxylamines are very reactive
nucleophiles and, since the N-O bond in the products can be hydrogenolysed,
nucleophilic substitution with a hydroxylamine provides a means for the introduction of
a second amine. Scheme 1.3 shows the use of a hydroxylamine as a ‘supernucleophile’
to displace a relatively unreactive chlorine.5
Scheme 1.3: The use of a hydroxylamine as a ‘supernucleophile’ to displace a
relatively unreactive chlorine
The oxydiazine can also undergo nucleophilic addition or displacement of
halide. Uracil5 and its riboside (uridine)5 are particularly prone to Michael-type addition
to the double bond leading to cine-substitution rather than the usual ipso-substitution,
for example from 5-bromouridine to the 6-cyanouridine shown in Scheme 1.4.
Scheme 1.4: Cine-substitution of a 5-bromouridine derivative
51.2. Pyrimidine
(1)
Pyrimidine is the most important member of all diazines as this ring system
occurs widely in living organisms. Pyrimidine (1), also known as m-diazine. Purines,
uric acid and barbituric acid also contain pyrimidine ring. The chemistry has been
widely studied. 8-11 Pyrimidine was first isolated by Gabriel and Colman in 1899. Since
pyrimidine is symmetrical about the line passing C-2 and C-5, the position C-4 and C-6
are equivalent and so are N-1 and N-3.12
In early history of organic chemistry, compounds belonging to this group were
known as breakdown products of uric acid, but the systematic study of the ring system
really began with the work of Pinner13, who first applied the name pyrimidine to the
unsubstituted parent body.
Pyrimidine is a colorless compound, melts at 22.5 ͦ C and boils at 124 ͦ C. It is
weakly basic (pKa 1.3) as compared to pyridine (pKa 5.2) or imidazole (pKa 7.2). The
decrease in its basicity is due to the electron-withdrawing effect of the second nitrogen
atom present in the ring. Moreover, the addition of the proton does not increase the
probability for mesomerism and hence the resonance energy. The presence of alkyl
groups, however, enhances the basicity, thus 4-methylpyrimidine has pKa 2.0 while 4,
6-dimethylpyrimidine has a value of 2.8. The 2- and 4-aminopyrimidines are more basic
with pKa 3.54 and 5.71 repectively. In these two compounds, more resonance structure
are possible in the cation than in the neutral molecule. The close relationship of
6pyrimidine with benzene suggests the former is also highly aromatic and the ring is
virtually planar.
Pyrimidine-containing molecules are paramount importance in nucleic acid
chemistry. Their derivatives including uracil, thymine, cytosine, adenine and guanine
are fundamental building blocks for deoxyribonucleic acid (DNA) and ribonucleic acid
(RNA). Vitamin B1 (thiamine) (2) is another well-known example of naturally occuring
pyrimidines encountered in our daily lives. Synthetic pyrimidine-containing compounds
occupy a prominent place in the pharmaceutical arena. Pyrimethamine (3) and
Trimethoprim (4) are two representative pyrimidine-containing chemotherapeutics.
Compound (3) is a dihydrofolate reductase inhibitor which is effective for
toxoplasmosis in combination with a sulphonamide whereas compound (4) is an anti-
malarial drug, widely used as a general systemic anti-bacterial agent in combination
with sulfamethoxazole.14-15
Due to the electronegativity of the two nitrogen atoms, pyrimidine is a
deactivated, π-electron-deficient heterocycle. Its chemical behaviour is comparable to
that of 1,3-dinitrobenzene or 3-nitropyridine. One or more electron-donating
substituents on the pyrimidine ring are required for electrophilic substitution to occur. In
contrast, nucleophilic displacement takes place on pyrimidine more readily than
pyridine. The trend also translates to palladium chemistry; whereby 4-chloropyrimidine
7oxidatively adds to Pd (0) more readily than does 2-chloropyridine. Remarkable
differences in reactivity for each position on pyrimidinyl halides and triflates have been
observed. The C-4 and C-6 positions of a halopyrimidine are more prone to SNAr
process than the C-2 position. The order of SNAr displacement for halopyrimidines is as
shown is Figure 1.3.14
Figure 1.3: The order of SNAr displacement for halopyrimidines
This trend is also observed in palladium chemistry where the general order for
oxidative addition often correlates with that of nucleophilic substitution. Not only are 2-
, 4- and 6- chloropyrimidines viable substrates for Pd-catalyzed reactions, but 4- and 6-
chloropyrimidines react more readily than 2-chloropyrimidines.14
Undheim and Benneche reviewed the Pd-catalyzed reactions of pyrimidines,
among other π-deficient azaheterocycles including pyridines, quinolines and pyrazines.
A review by Kalinin also contains some early examples in which C-C formation on the
pyrimidine ring is accomplished using Pd-catalyzed reaction.14
81.2.1 Ring synthesis of pyrimidines
1.2.1.1 Pinner Pyrimidine Synthesis
The condensation of 1,3-dicarbonyl compounds (6) with amidines (7) catalyzed
by acids or bases to give pyrimidine derivatives (8) is generated as the Pinner13
pyrimidines synthesis as shown in Scheme 1.5
Scheme 1.5: Pinner pyrimidine synthesis
In the 1880’s, Pinner found that the amidine derivatives (7) reacted with
acetoacetic ester (9) to furnish 2-substituted-6-hydroxy-4-methylpyrimidine (10)16. The
condensation of amidine derivative (7) with other β-keto ester, malonic ester, and β-
diketones proceed similarly. Scheme 1.6 shows the synthesis of 2-substituted-6-
hydroxy-4-methylpyrimidine.
Scheme 1.6: Synthesis of 2-substituted-6-hydroxy-4-methylpyrimidine
Although the Pinner pyrimidine synthesis was disovered a century ago, a few
reports on the reaction mechanism have appeared. The condensation of acetylacetone,
9methyl acetoacetate, or dimethyl malonate with acetamide (11) has been studied by
Kartrizky et-al. The reaction mechanism for these processes has been proposed by
these authors. Scheme 1.7 shows the proposed mechanism of the condensation of
methyl acetate (9) with acetamide (1116).
Scheme 1.7: Proposed mechanism of the condensation of methyl acetate (9) with
acetamide (11).
Other than that, a compound that includes an aminopyrimidine ring as well as
the quaternary salt present in thiamine shows preferential inhibition of absorption of
that co-factor by coccidia parasites over uptake by vertebrates. The compound is thus
used in poultry where coccidiosis is an economically important disease. Condensation
of ehtoxymethylenemalonitrile (12) with the amidine (13) aminopyrimidine (14). The
reaction was probably occurred via addition-elimination intermediate (15). The nitrile
group is then reduced to the methylamino derivative (16) by means of lithium
aluminium hydride. Exhaustive methylation, for example by reaction with
formaldehyde and formic acid, followed by methyl iodide leads to the quaternary
methiodide (17). The quaternary salt is then displaced by bromine to form benzylic-like
cyclic halide, (18) which was then displaced by 2-picoline (19). Finally, amprolium
(20)17was obtained. Scheme 1.8 shows the mechanism of formation of (20).
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Scheme 1.8: Formation of amprolium (20)
1.2.1.2 Antiviral pyrimidines
Viruses differ from bacteria and fungi in most fundamental way in that they are
not able to reproduce independently. A virion in essence consists of a chain of DNA or
RNA in the case of a retrovirus, packaged with a small group of specialized proteins.
The virus actually replicates by taking over the infected cells’ reproductive apparatus, in
effect causing the cell to synthesize new virions. Chemotherapy of viral disease must
thus rely on very subtle biochemical differences between normal and infected cells
instead of the large divergences in biochemistry between microbial and host cells that
provide the basis of antibiotics. The somewhat lesser discriminatory power of the
enzymes in viral cells for the nucleotides involved in replication has made it possible to
identify a number of closely related false substrates.
The nucleotide, uridine (21) provides the starting material for one of these
agents. Treatment of (21) with mercuric chloride leads to the mercuration of the
11
pyrimidine ring to afford (22). Reaction of this organometallic derivative wih ethylene
in the presence of a platinum salt leads to the formation alkylated product (23).
Catalytic hydrogenation of the double bond then affords the antiviral compound
edoxudine (24)17. Scheme 1.9 shows the mechanism of formation of edoxudine (24)
Scheme 1.9: Formation of edoxudine (24)
Similar chemistry is used to prepare the antiviral agent sorivudine (29); this
compound is also endowed with an unnatural sugar in the arabinose configuration. The
side chain is attached as above by chloromercuration of uracyl arabinoside (25).
Reaction of the organometallic (26) with ethyl acrylate leads to the coupling product
(27). The ester group is then saponified to the corresponding acid (28). Treating the acid
with N-bromosuccinimide leads to a Borodin-like replacement of the carboxyl group by
bromine. The resulting reactive allylic halogen in the product, sorivudine (29)18, may
play a role in the compound’s activity against herpes virus. Scheme 1.10 shows the
formation of soruvidine (29).
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Scheme 1.10: Formation of soruvidine (29)
1.3 Pyrazine
(30) (31)
The pyrazines (30) are aromatic compounds as well as tertiary amines, and their
properties are closely resemble to those of pyridines. The pyrazines nucleus may be
considered as a resonance hybrid of which two of the contributing forms are analogous
to those of benzene. The C-N bond distances in pyridine and pyrazine, however, are
slightly greater because of the high electronegativity of the nitrogen atom which
probably leads to significant additional contributions to the resonance by structure (31).
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The electronegativity of the two nitrogen atoms would be expected to have a definite
influence on both the basic and the aromatic properties of pyrazines.
Pyrazine is a low-melting solid and most of the lower homologs are liquids at
room temperature. The pyrazines in general possess a narcotic odor, sublime readily and
may be distilled with steam. Like many other amines, the pyrazines from hydrates and
on removal of the water of often results. The lower members of the series are very
soluble in water, and several are miscible in all proportions.
The preparation of ‘amarone’ in 1844 by Laurrent is the first recorded synthesis
of a pyrazine. Laurent’s method was obscure, however, and it was more than fifty years
later that “amarone” was identified as tetraphenylpyrazine.19 Meanwhile the systematic
study of this series of compounds was initiated by Victor Meyer’s students, Gutknecht
and Treadwell, who found that the reduction of nitrosated ketones resulted in the
formation of oxygen-free bases instead of the expected α-amino ketones as shown in
Scheme 1.11.20
Scheme 1.11: Reduction of nitrosated ketones
The correct structure for the ring system of the product was first advanced by
Wleugel21, and the synthesis of pyrazine derivative by another method appeared to
confirm this structure and established the correct positions of the substituents. Finally,
in 1893 Wolff’s conversion of tetramethylpyrazine to piperazine by the series of
14
reactions indicated in Scheme 1.12 provided unequivocal proof of the structure of
pyrazines.22
Scheme 1.12: Wolff’s conversion of tetramethylpyrazine to piperazine
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CHAPTER 2:  FLUORESCENCE SPECTROSCOPY 
2.1 Introduction 
 
Fluorescence spectroscopy is a spectroscopic technique whereby fluorescent 
substances are being examined. Fluorescence spectral data are generally presented as 
emission spectra. A fluorescence emission spectrum is a plot of the fluorescence 
intensity versus wavelength (nanometers) or wavenumbers (cm-1). There are two types 
of fluorescence sampling measurement which are in solid or solution.23 In this study all 
samples were measured in solution. In solution, at normal temperatures, fluorescence 
occurs at a longer wavelength.  It has a number of advantages over other forms of 
microscopy that offer high sensitivity and specificity. Because fluorescence is observed 
as luminosity on a dark background, particular constituents of the specimen can be seen 
even in extremely small amounts.24    
 
The first observation of fluorescence is from a quinine solution in sunlight was 
reported by Sir John Frederick William Herschel in 1845.25 He recognized the presence 
of an unusual phenomenon that could not be explained by the scientific knowledge of 
the time. The first known fluorophore, quinine was responsible for stimulating the 
development of the first spectrophotometers that appeared in 1950s. Nowadays quinine 
sulphate (33) and fluorescein (34) are widely used as references for the fluorescence.  
 
 
                                (33)                                         (34) 
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The research was then reinvestigated by Stokes, who published a famous paper 
entitled ‘On the Refrangibility of Light’ in 1852.26 The fluorescence normally observed 
in solution is called Stokes fluorescence. If thermal energy is added to an excited state 
or a compound has many highly populated vibrational energy levels, emission at shorter 
wavelengths than those of absorption can occurs.  
 
2.2 Interaction of light with a molecule 
 
When a molecule is placed in an oscillating electromagnetic field (light is shone 
on the molecule), the oscillating fields can push and pull the molecule around. In 
particular, charged parts of the molecule are affected by the oscillating electric field of 
light; the effect of the oscillating field is much weaker. If the charges on the molecule 
can oscillate in synchrony with the oscillating field (this is called resonance), the 
molecule can absorb energy from the field.  
 
 Molecules have specific resonance frequencies. For example, a typical C-H bond 
in a molecule vibrates about 1014 times per second (1014 Hz), while a C-C bond vibrates 
at about 3 x 1013 Hz. Electrons are over 1000 times lighter than nuclei and oscillate at 
even higher frequencies. A typical frequency of light absorbed by valence electrons is 
1015 Hz, which is 30 times faster than the C-C bond vibration. Light with this frequency 
corresponds to the near-UV region of the spectrum. More generally, the range of 
wavelengths absorbed by valence electrons varies from about 1000 nm i.e near IR 
through the visible and UV down to about 100 nm i.e far UV.  
 
 Absorption of electromagnetic radiation and excitation of electrons take more or 
less instantaneously (~10-18 s) relative to nuclear motion (~10-15 s), according to the 
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Franck-Condon Principle. Despite this difference in times scales, excitation of electrons 
in a molecule can also cause a change in molecular structure. The absorbed energy leads 
to a redistribution of the electron cloud of the molecule, resulting in altered vibrational 
levels, an altered dipole moment and a change in the shape of the molecule. Quite 
simply, the bonds are not the same after an electron has been removed and more into a 
different orbital. Consequently, the electronic absorption is often accompanied by 
vibrational motion as the atoms move to their new positions23-25.  
 
 Excited states of molecules are unstable. They relax (lose their energy) by a 
number of mechanisms including collisions with other molecules, for example, the 
solvent, or react with other species for example dissolved oxygen. The excited molecule 
may also relax by emitting a photon of light to return to a lower state, though not always 
the same lower state from which it came. The emitted photon was an energy 
corresponding to the difference in energy between the initial and final states of the 
molecule. This emission of a photon is known as fluorescence or some cases 
phosphorescence23-25. 
 
2.3 Jablonski diagram 
 
Jablonski diagram is originally showing that the fluorescent state of a molecular 
entity is the lowest excited state from which the transition to the ground state is allowed, 
whereas the phosphorescent state is a metastable state below the fluorescent state, which 
is reached by a radiationless transition. In the most typical cases the fluorescent state is 
the lowest singlet excited state and the phosphorescent state the lowest triplet state, the 
ground state being a singlet. Presently, modified Jablonski diagrams are frequently used 
and are actually state diagrams in which molecular electronic states, represented by 
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horizontial lines displaced vertically to indicate relative energies, are grouped according 
to multiplicity into horizontially displaced columns. Excitation and relaxation processes 
that interconvert states are indicated in the diagrams by arrows. Radiative transition are 
generally indicated with wavy arrows.27  
 
Therefore, on the Perrin-Jablonski diagram, the absorption transition is shown as 
starting in the ground state. There is no such restriction on the excited state; therefore 
absorption may occur to a variety of vibrational states in the excited electronic states. 
The typical amount of vibrational excitation, as discussed above, depends on the change 
in the geometry of the molecule between the two different electronic states. Small 
changes in geometry are accompanied by small vibrational excitation (arrow 1) whereas 
large changes in geometry are accompanied by large vibrational excitation (arrow 2) as 
show in Figure 2.1.  
 
Essentially, to be absorbed, the energy of the incident radiation must exactly 
match one of the available energy-level transitions. Given the many possible 
combinations of electronic and vibrational energy levels for a polyatomic molecule, a 
range of light energies may be absorbed. The energy of the light is proportional to its 
frequency (thus inversely related to its wavelength), so a given molecule will absorb a 
specific set of wavelengths of light, giving rise to its absorption spectrum.  
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Figure 2.1: Simple Perrin-Jablonski diagram showing three electronic states, 
several vibrational states, absorption and emission of fluorescence or 
phosphorescence 
 
The Perrin-Jablonski diagram in Figure 2.1 shows absorption to both S1 and T1. 
In reality, the transition from S0 to T1 is weaker than S0 to S1. Absorption into triplets 
states, as shown in the Figure 2.1 is therefore practically unimportant in most cases and 
is only observed in specialized situations in spectroscopy. The population of triplet 
states is one of the main mechanisms for photobleaching. It is simple and fortuitous, but 
triplets are not populated to any great extent by absorption of light by molecules 
commonly used in fluorescence spectroscopy and microscopy.   
 
 Emission of light is shown on a Perrin-Jablonski diagram as an arrow from the 
excited state back to the ground state. Emission that does not change electron spin, just 
like absorption, is much preferred over emission in which the electron spin is flipped. 
This spin-conserving emission is called fluorescence. Since the process is favourable, it 
happens readily and quickly, as a result the excited electronic states survive for only a 
very short period of time, typically a few nanoseconds before emitting. Emission 
T1 
Absorption 
Fluorescence 
Absorption 
Phosphorescence 
S0 
S1 
(2) 
(1) 
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between triplet and singlet states is called phosphorescence. This emission is weak and 
therefore involves a slow process. As the result the molecule remains excited much 
longer, typically milliseconds to seconds. The process is slow compared to molecular 
events. It give rise to an unusual chemistry in the excited state leading to the reduction 
in fluorescence efficiency, photobleaching and other processes. 
 
2.4 Instrumentation 
 
A schematic representation of a fluorimeter is shown in Figure 2.2. The light 
source produces light photons over a broad energy spectrum, typically ranging from 220 
to 900 nm. Photons impinge on the excitation monochromator, which selectively 
transmits light passes through adjustable slits that control magnitude and resolution by 
further limiting the range of transmitted light. The filtered light passes through the 
sample cell causing fluorescent emission by fluorophores within the sample. Emitted 
light enters the emission monochromator, which is positioned at 90° angle from the 
excitation light path to eliminate background signal and minimize noise due to stray 
light. Again, emitted light is transmitted in a narrow range centered about the specified 
emission wavelength and exits through adjustable slits, finally entering the 
photomultiplier tube (PMT). The signal is amplified and creates a voltage that is 
proportional to the measured emitted intensity. Noise in the counting process arises 
primarily in the PMT. Therefore, the spectral resolution and the signal-to-noise ratio is 
directly related to the selected slit widths. Since the source intensity may vary over 
time, most research-grade fluorimeters are equipped with an additional ‘reference PMT’ 
which measures a fraction of the source output just before it enters the excitation 
monochromator, and used to ratio the signal from the sample PMT. 
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Not all fluorimeters are configured as described above. Some instruments 
employ sets of fixed band pass filters rather than variable monochromators. Each filter 
can transmit only a select range of wavelengths. Units are usually limited to 5 to 8 filter 
and are therefore less flexible. Fiber optics are also employed for “surface readers”, to 
transmit light from the excitation monochromators to the sample surface and then 
transport emitted light to the emission monochromators. This setup has the advantage of 
speed, but has the signal to noise ratio is increased, due to the inline geometry, and 
smaller path length which increase the probability of quenching.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2:  Schematic representation of a fluorescence spectrophotometer. 
 
Fluorescent methods have two significant advantages over absorption 
spectroscopy. First, two wavelengths are used in fluorimetry, but only one in absorption 
spectroscopy. Emitted light from each fluorescent color can be easily separated because 
each color has a unique and narrow excitation spectra. This selectivity can be further 
22 
 
enhanced by narrowing the slit width of the emission monochromator so that only 
emitted light within a narrow spectral range is measured. Multiple fluorescent colours 
within a single sample can be quantified by sequential measurement of emitted intensity 
using a set of excitation and emission wavelength pairs specific for each color. The 
second advantage is that fluorescent methods have a greater range of linearity. Because 
of these differences, the sensitivity of fluorescence is approximately 1,000 times greater 
than absorption spectrophotometric methods.28 
 
2.4.1 Perkin Elmer LS-50B   
 
In this study all fluorescence data were measured with a Perkin Elmer LS-50B 
Luminescence Spectrometer. To obtain accurate data, it is necessary to understand 
several key aspects of fluorescence spectrophotometry and how these pertain to the use 
of the LS-50B spectrometer. 
 
All fluorescence instruments contain three basic elements: a source of light, a 
sample holder, and a detector. To be of analytical utility, a system must be equipped 
with adjustable monochromators that can accurately select excitation and emission 
wavelengths. It is also essential to monitor and correct any fluctuations in the source 
intensity. The Perkin Elmer LS-50B Luminescence Spectrometer measure the 
fluorescence intensity of samples in either a continuous scan over a range of wavelength 
or at select excitation and emission wavelength pairs. Sections 2.4.1.1 to 2.4.1.6 explain 
the fluorescence instrument basic elements.  
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2.4.1.1 Preparation of sample 
 
Before any analytical experiment is carried out, the compounds must be pure. 
Since fluorescence technique is a very sensitive technique, it is extremely susceptible to 
interference by contamination of trace level of organic chemicals. Thus, the solvents 
used are at highest level of purity and commercially obtained.  
 
2.4.1.2 The Xenon source 
 
In this study the source that has been employed is a pulsed Xenon flash lamp. It 
produces a high output using a low voltage, 9.9 watts, resulting in longer lamp life with 
minimal ozone and heat production. Equally important, the pulsed source reduces 
potential photobleaching of the pyrimidines and pyrazines sample, during analysis, by 
several orders of magnitude over continuous sources. Xenon flash lamp produces a 10 
µsec pulse of radiation in 16 msec. In fluorescence mode, the photomultiplier tube 
detector is gated for an 80 msec period in synchronization with the lifetime of the lamp 
pulse.  
 
2.4.1.3 Photomultiplier tube 
 
A photomultiplier dark current is acquired prior to the onset of each lamp pulse 
and is substracted from pulse for correction of phototube dark current. The instrument 
measures and corrects every flash of the lamps to improve sensitivity at low levels of 
fluorescence25, making it possible to measure samples at room light. 
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2.4.1.4 Determining fluorescence ratios  
 
The intensity of emitted light depends on a number of factors, including 
intensity of incident exciting light i.e the more powerful the exciting light, the stronger 
the emitted fluorescence intensity. All light sources currently used in the fluorescence 
instrumentation normally lack of stability over long periods. This causes the output of a 
xenon lamp to fluctuate at a function of time, in which affects the measured 
fluorescence intensity of a given sample with all other conditions being equal. In order 
to perform accurate quantitative analyses, these fluctuations must be monitored and 
corrected to the measured fluorescence intensity. The LS-50B can automatically make 
this correction by determining the ratio of real-time lamp intensity over sample 
intensity. The lamp intensity is then monitored continuously with a beam splitter to 
divert a portion of the exciting light to a reference photomultiplier tube.  
 
2.4.1.5 Signals processing  
 
When operated in wavelength programming mode, the instrument automatically 
sets the excitation and emission wavelength for each sample and dwell time for the 
specified integration time. The instrument then averages the appropriate number of lamp 
pulse cycles for the specified integration time. Longer integration time reduces the 
signal-to-noise ratio for the sample fluorescence intensity. When calculating the optimal 
sample integration, there are 60 lamp pulses per sec and the noise in a sample 
measurement is reduced by the square-root of the number of lamp pulse used. Due to 
this, relationship between noise reduction and pulse number, there is a point of 
diminishing return for long integration times. An integration time exceeding 2 sec is 
only necessary when small fluorescence intensities are being measured. 
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2.4.1.6 Slit setting   
 
An important feature of the LS-50B is the availability of continuous variable slit 
adjustment with 0.1 nm increments on both the excitation and emission 
monochrometers. The flexibility allows the user to ‘fine–tune’ the instrument for both 
selectivity and sensitivity in dye discrimination and measurement. The slits can best be 
described as volume controls for the fluorescence intensity. For optimal instrumental 
performance, the excitation slit width automatically controls the sample photomultiplier 
tube voltage. This provides an optimum signal-to-noise ratio as a function of sample 
intensity.  
 
 In general, a wider slit setting causes higher fluorescence signal measurements. 
However, because of the fluorescence ratio system used in the LS-50B, widening of the 
excitation slit width will not increase the reported fluorescent signal ratio, but will 
increase sample fluorescence signal, resulting in an improved signal-to-noise ratio.  
 
2.5   Environmental effects 
2.5.1 Solvent polarity 
 
Emission from fluorophores generally occurs at wavelengths that are longer than 
those at which absorption occurs. This loss of energy is due to a variety of dynamic 
processes that occur following the light absorption. The fluorophore is typically excited 
to the first singlet state (S1) usually to an excited vibrational level within S1. The excess 
vibrational energy is rapidly lost to the solvent. If the fluorophore is excited to the 
second singlet state (S2), it rapidly decays to the S1 state in 10-12 sec due to internal 
conversion. Solvent effects shift the emission to lower energy due to the stabilization of 
26 
 
the excited state by the polar solvent molecules. Typically, the fluorophore has a larger 
dipole moment in the excited state than in the ground state. Following the excitation the 
solvent dipoles can re-orient or relax around which lowers the energy of the excited 
state. As the solvent polarity is increased, this effect becomes larger, resulting in the 
emission at lower energies or longer wavelengths. In general, only fluorophores that are 
themselves polar display a large sensitivity to solvent polarity. Nonpolar molecules, 
such as unsubstituted aromatic hydrocarbons are much less sensitive to solvent polarity. 
 
 Fluorescence lifetime (1-10 nsec) is usually much longer than the time required 
for solvent relaxation. For fluid solvents at room temperature, solvent relaxation occurs 
in 10-100 psec. For this reason, the emission spectra of fluorophores are representative 
of the solvent relaxed state. Absorption of light occurs in about 10-15 sec, a time too 
short of motion for fluorophore or solvent. Absorption spectra are less sensitive to 
solvent polarity because the molecule is exposed to the relaxed environment, which 
contain solvent molecules oriented around the dipole moment of the excited state.  
 The theory for solvent effect is often inadequate to explain the detailed 
behaviour of fluorophores in a variety of environment. This is because fluoropores often 
display multiple interactions with their local environment, which can shift the spectra by 
certain wavelength comparable to general solvent effects.  
 
 In addition to specific solvent-fluorophore interactions, many fluorophores can 
form an ‘Internal Charge Transfer’ (ICT) state, or a ‘Twisted Internal Charge Transfer’ 
(TICT) state. For instance, suppose the fluorophore contains both an electron-donating 
and an electron-accepting group. Such group could be amino and carbonyl groups, 
respectively, but numerous other groups are known. Following the excitation, there can 
be an increase in charge separation within the fluorophore. If the solvent is polar, then a 
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species with charge separation (the ICT state) may become the lowest energy state. In a 
non-polar solvent the species without charge separation, so-called ‘Locally Excited’ 
(LE) state, may have the lowest energy. Hence, the role of solvent polarity is not only 
affect the energy of the excited state due to general solvent effects, but also to govern 
which state has the lowest energy. In some cases, formation of the ICT state requires 
rotation of groups on the fluorophore to form the TICT state. Formation of the ICT 
states is not contained within the theory of general solvent effects. Additionally, a 
fluorophore may display a large spectral shift due to excimer or exciplex formation. The 
fluorophore may be fluorescent or nonfluorescent in these different states. The quantum 
yield can change due to change in the rate of non-radioactive decay or due to a 
conformational change in the fluorophore.  
 
  In summary, no single theory can be used for a quantitative interpretation of the 
effects of environment on fluorescence. Interpretation of these effects relies not only on 
polarity consideration, but also on the structure of the fluorophore and the types of 
chemical interactions it can undergo with other nearby molecules. The trends observed 
for solvent polarity follow the theory for general solvent effects, which may give the 
impression that the solvent polarity is the only factor to consider. In reality, multiple 
factors affect the emission of any given fluorophore.25  
 
2.5.2  Oxygen 
 
 The intensity of fluorescence can be decreased by a wide variety of 
processes. Such decreases in intensity are called quenching. Quenching can occur by 
different mechanisms. Collisional quenching occurs when the excited-state fluorophore 
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is deactivated upon contact with some other molecule in solution, which is called the 
quencher. The molecules are not chemically altered in the process.   
 
A wide variety of molecules can act as collisional quenchers. Examples include 
oxygen, halogens, amines and electron-deficient molecules like acrylamide. In this 
dissertation the focus is on the effect of the presence of oxygen in the fluorescence 
sample. The mechanism of quenching varies with the fluorophore-quencher pair. For 
instance, quenching of indole by acrylamide is probably due to the electron transfer 
from indole to acrylamide, which does not occur in the ground state. Quenching by 
halogen29-30 and heavy atoms31-33 occur due to spin-orbital coupling and intersystem 
crossing to the triplet state. 
 
Aside from collisional quenching, fluorescence quenching can occur by a variety 
of other processes. Fluorophores can form nonfluorescent complexes with the 
quenchers. This process is referred to as static quenching34 since it occurs in the ground 
state and25. 
 
2.5.3  pH 
 
The addition of Bronsted acids or bases to the solvents in which absorbing, 
fluorescing or phosphorescing molecules are studied can affect the electronic spectra in 
two ways. If the acidity of the medium after the addition of acid or base is insufficient 
to protonate lone or non-bonded electron pairs or to abstract a proton from a dissociable 
group, the acid or base may form hydrogen bonds with the basic or acidic groups of the 
molecule of spectroscopic interest. The effects of these types of hydrogen bonding upon 
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the electronic spectra are similar to those described for hydrogen bond donor and 
acceptor solvents. 
  
 In some cases, aromatic molecules having non-bonded electron pairs fail 
to fluoresce in a non-hydrogen-bonding solvent because the lowest excited singlet state 
is of the n, pi* types and favors radiationless intersystem crossing as a mode of 
deactivation of the lowest excited singlet state. The addition of small amount of acid 
results in the formation of hydrogen bonding with the non-bonded pairs often raising the 
energy of the n, pi* state to such a degree that the lowest pi, pi* states become the lowest 
excited singlet state, making fluorescence likely. In this regard, several nitrogen 
heterocyclics, such as quinoline and acridine and some aromatic carbonyl compounds 
such as 2-acetonaphthone and pyrene-3-aldehyde do not fluoresce but phosphoresce. 
This addition of small amounts of acids such as trifluoroacetic acid or trichloroacetic 
acid, which are fairly soluble in hydrocarbons, results in appearance and decrease in the 
intensity of phosphorescence from these molecules.  
 
If the acidity of the medium is sufficient to protonate functional groups having 
lone or non-bonded electron pairs, or to abstract a proton from acidic functional groups, 
the effects on the electronic spectra are more dramatic but qualitatively similar to the 
effects produced by hydrogen bonding. Protonation of a basic molecule, or dissociation 
of an acidic molecule, produce a chemical species whose reactivity and electronic 
structure are different from that of the original molecule. However, protonation is 
similar to the interaction with a hydrogen-bond donor solvent in that a positive 
polarizing influence is affected at the protonated functional group, while dissociation is 
similar to interaction with a hydrogen-bond acceptor solvent in that the removal of a 
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positively charged proton is equivalent to a negative polarizing influence at the 
dissociated group.  
 
Following the lines of reasoning developed for hydrogen-bonding effects on 
electronic spectra, some generalization can be made. Protonation of non-bonded pairs 
on functional groups in the excited state enhances the acceptor properties of these 
groups and results in stabilization of the excited states relative to the ground state. 
Protonation of these types of functional groups therefore produces shifting of the 
intramolecular, electronic, charge-transfer spectra to longer wavelengths. However, the 
n, pi* states giving rise to n, pi* transitions (which are usually seen only in the absorption 
spectra) of these molecules are raised in energy to such an extent by protonation that 
they disappear completely from the absorption spectra. Protonation of lone pairs on 
functional groups that are charge-transfer donors in the excited states (e.g –NH2) 
inhibits the donor properties of these groups and results in shifting of the electronic 
spectra to shorter wavelengths8. 
 
2.6   The chemical structure and the fluorescence  
 
The nature of substituents (especially chromophoric ones) plays an important 
role in the nature and extent of a molecule’s fluorescence.  Substituent effects on the 
chemical and physical properties of organic molecules in their ground electronic states 
constitute a lively area of investigation at present. Furthermore, only little is known 
about the influence of substituents on the behaviour of the excited states. Both effects 
must be understood before generalizations concerning the effect of various substituent 
groups can be made.  
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 A simple generalization is that ortho-para-directing substituents often enhance 
fluorescence, whereas meta-directing group repress it as shown in Table 2.1. Many of 
the common meta-directing substituents, possess low-lying (n, pi*) singlets. The –NO2 
group is especially notorious for repressing fluorescence. Carbonyl substituents (ketone, 
aldehyde, ester, carboxylic acid), which are meta-directing, repress fluorescence 
because carbonyl-substituted aromatic possess low-lying (n, pi*) singlets.35  
 
 The –CN substituent is meta-directing, yet cyno-substituted aromatics often 
fluoresce more intensely than the parent hydrocarbon. Evidently, (n, pi*) singlet states in 
cynoaromatics are sufficiently higher in energy than the lowest (pi, pi*) singlet for the 
former to have no significant perturbing effect. 
 
 Some ortho-para-directing substituents (-OH, -NH2, -OCH3) tend to enhance the 
fluorescence of aromatic compounds. Great care must be exercised in discussing the 
effect of these substituents because they have a strong tendency to form hydrogen-bond 
with the solvent or occasionally with other solute. For example, the dissociated –OH 
group (-O-) is a strongly ortho-para-directing group, yet most phenolates are less 
fluorescent than their conjugated acids. In most cases ionized phenols interact very 
strongly with the solvent, increasing the efficiency of S1*→S0 internal conversion. In 
other words, for aromatic compounds with acidic or base functional groups, it is 
inherently impossible to separate ‘structural” from “environmental” effects on their 
luminescence behaviour.  
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Table 2.1: The effect of substituents on the fluorescence of aromatics36 
Substituent Effect on frequency 
of emission 
 
Effect on intensity 
Alkyl None Very slight increase or 
decrease 
-OH, -OCH3, -OC2H5 Decrease Increase 
CO2H Decrease Large decrease 
NH2,NHR, NR2 Decrease Increase 
NO2 Large decrease Large decrease 
CN None Increase 
SH Decrease Decrease 
F Decrease Decrease 
Cl Decrease Decrease 
Br Decrease Decrease 
I Decrease Decrease 
SO3H none none 
 
2.7   Objectives of study 
 
The main objectives of this study is first to synthesize a series of phenoxy 
derivatives of pyrimidine and pyrazine. The second objective is to study the 
fluorescence characteristic of all compounds prepared with respect to: 
i. solvents 
ii. substituents 
iii. concentrations 
iv. pH 
v. effect of oxygen 
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CHAPTER 3:  RESULTS AND DISCUSSION 
3.1 Synthesis of the compounds studied 
In this study, eleven compounds have been synthesized which consist of 
nine phenoxypyrimidines and two phenoxypyrazines. Details of synthesis are 
described in chapter five. Reaction equation of 2-chloropyrimidine (35) with a 
phenol and its derivatives are as shown in Figure 3.1  
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Figure 3.1: Reactions of 2-chloropyrimidine (35) with phenol and its 
derivatives 
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Reaction of 2-chloropyrazine (54) with o-methoxyphenol (36) and p-
methoxyphenol (38) were as shown in Figure 3.2 
 
N
N
Cl
N
N
O
N
N
O
O
OH
O
OH
O
O
(54)
(38)
(55)
(36)
(55)
 
 
Figure 3.2: The reaction of 2-chloropyrazine (54) with o-methoxyphenol 
(36) and p-methoxyphenol (38).  
 
The structures of all prepared compounds were confirmed by IR, 1H 
NMR, 13C NMR and GC-mass spectra. The detailed spectra are attached in 
Appendices section.  
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 Reaction of 2-chloropyrimidine (35) with o-methoxyphenol (36), p-
methoxyphenol (38), phenol (40), m-methoxyphenol (42), o-cresol (44), 1,2-
dihydroxybenzene (46), m-nitrophenol (48) and p-cresol (50)  were carried out 
using classical Williamson ether synthesis.37 The Williamson ether synthesis is 
one of the best methods for preparing ethers. The reactions mechanism of this 
reaction is as shown in Scheme 3.1 
 
OH
+ NaOH (aq)
N
N
Cl
+
N
N
Cl
O
N
N
O
(35)
R = H, -CH3, -OCH3, -NO2, -OH
R
O-Na+
R
O-Na+
R R
R
 
 
Scheme 3.1: The reaction mechanism of 2-chloropyrimidine (35) with 
phenol and its derivatives 
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Similarly, 2-chloropyrazine (54), reacted with either o-methoxyphenol (36) or p-
methoxyphenol (38) via William ether synthesis. The reaction mechanism of 2-
chloropyrazine (54) with phenol derivatives is as shown in Scheme 3.2. 
OH
+ NaOH (aq)
O-Na+
O-Na+
N
N
Cl
+
N
N
Cl
O
N
N
O
(54)
R = -OCH3
R
R
R R
R
 
 
Scheme 3.2:  The reaction mechanism of 2-chloropyrazine (54) with phenol 
derivatives 
 
3.2 Synthesis of phenoxypyrimidines  
3.2.1 Reactions of 2-chloropyrimidine with various phenols 
 
Reactions of 2-chloropyrimidine (35) with o-methoxyphenol (36), p-
methoxyphenol (38), phenol (40), 3-methoxyphenol (42), o-cresol (44), 1, 2-
dihydroxybenzene (46), 3-nitrophenol (48) and p-cresol (50) were studied as shown in 
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Figure 3.1. 2-(2-Methoxyphenoxy)pyrimidine (37) was obtained when o-
methoxyphenol (36) was added to sodium hydroxide and 2-chloropyrimidine (35). 60% 
of the pure product was obtained after recrystallisation from ethyl acetate. The structure 
of (37) was confirmed by IR, 1H NMR, 13C NMR and GC mass spectra.  
N
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(37) 
The mass spectrum showed an [M+] peak at m/z 202 corresponding to the 
molecular formula of C11H10N2O2. The 1H NMR spectrum showed a doublet with 
coupling constant of 4.9 Hz at δ 8.54 which represented H-4 and H-6, while a multiplet 
at δ 7.22 was assigned to H-5. Two sets of multiplets at δ 7.01 for H-3’, H-4’ and H-5’ 
but H-6’ at δ 7.22 while hydrogen of the methoxy group was observed as a singlet at δ 
3.74.  
 
The 13C NMR spectrum showed a total of ten signals attributable to eleven 
carbons which consist of methoxy carbon, 6 methine carbons and 3 quaternary carbons, 
which are in agreement with the corresponding molecular formula of (37).  The 
relatively low intensity of quaternary carbon at δ 165.2 was assigned to C-2 of the 
pyrimidine ring, while signal at δ 159.5 was assigned to carbons C-4 and C-6. Two 
signals at δ 151.5 and δ 141.8 were assigned to C-2’ and C-1’ of quaternary carbons, 
while signal at δ 112.7 was attributable to C-5 of pyrimidine ring. The signal at δ 122.7 
– δ 112.7 were assigned to C-3’, C-4’, C-5’ and C-6’ of the o-methoxyphenoxide 
moiety. The upfield signal at δ 55.8 is notable for the presence of a methoxy group.  
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The infrared spectrum showed a strong absorption band at 1569 and a medium 
absorption bands at 1498 and 1404 which were due the presence of C=N stretching and 
aromatic C=C stretching respectively. A strong band observed at 1302 and 1023 were 
typical of C-O stretching bands. 
 
Reaction of 2-chloropyrimidine (35) with 4-methoxyphenol (38) gave 50% yield 
of colourless crystal of (39). The structure of (39) was confirmed by spectroscopic 
methods. The mass spectrum displayed an [M+] peak at m/z 202 which is consistent 
with the molecular formula C11H10N2O2. 
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(39) 
The 1H NMR spectrum of (39) showed similar profiles with those of (37). The 
differences were observed as two doublets (J= 9.3 Hz) at δ 7.14 and δ 6.96, which were 
assigned for H-2’/H-6’ and H-3’/H-5’ respectively. 
 
The 13C NMR spectrum showed a total of 8 signals which represented 11 
carbons. Out of 8 peaks, six peaks showed similar profiles as compared to (37). The 
differences were observed for signals at δ 122.5 and δ 114.7, each represented 2 
aromatic of C-2’/C-6’ and C-3’/C-5’ respectively. The IR spectrum of (39) displayed 
similar absorptions to that of (37).  
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2-Phenoxypyrimidine (41) was obtained when phenol (40) was allowed to react 
with 2-chloropyrimidine (35). The GC-mass spectrum displayed the [M+] peak at m/z 
172 which is consistent with the molecular formula C10H8N2O. 
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(41) 
The 1H NMR spectrum of (41) showed a downfield doublet at δ 8.5 which 
attributable to H-4 and H-6 of (37). A triplet at δ 7.42 with coupling constant of 6.6 Hz 
was due to H-3’ and H-5’ while a doublet at δ 7.23 with coupling constant of 5.8 Hz 
was assigned to H-4’while another doublet (J= 7.6 Hz) at δ 7.18  was attributable to H-
2’ and H-6’. A downfield triplet (J= 4.9 Hz) at δ 7.01 was consistent to H-5 of the 
pyrimidine ring. 
 
A total of seven signals which represented 10 carbon atoms were observed in the 
13C NMR spectrum of (41). However, only three signals, δ 165 (C-2), δ 160 (C-4/C-6) 
and δ 153 (C-1’) were similar as compound (37). In addition, two signals at δ 129.6 and 
δ 116.1 were attributable to C-3’/C-5’ and C-2’/C-6’ respectively. The remaining two 
signals at δ 125.5 and δ 121.6 were assigned to C-4’ and C-5 respectively. The IR 
spectrum showed similar absorption bands as compounds (37). 
 
Ultimately, the correct structure of (41) was determined by X-ray 
crystallography analysis. The crystal system was found to be monoclinic and the 
refinement data are as shown in Table 3.1, while Figure 3.3 showed the ORTEP 
diagram of (41).   
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Table 3.1: The crystal system and refinement data of (41) 
Crystal data and structure refinement for 2-phenoxypyrimidine (41). 
Chemical formula  C10H8N2O 
Molecular weight 172.18 
Crystal system  Monoclinic,  
T (K) 100 (2)  
Space group P21/c 
a (Å) 10.859 (1)  
b (Å) 20.181 (2)  
c (Å) 8.1339 (8)  
β (º) 106.637 (2) 
V (Å3) 1707.8 (3)  
Z  8 
Dcalc  Mg m−3 1.339 
Absorption coefficient µ (mm−1) 0.09  
F000   720 
Crystal size (mm) 0.25 × 0.20 × 0.15  
θ range for data collection 2.2–28.2º 
Index ranges (-11, -26, -10) to (14, 26, 10) 
Reflections collected 9752 
Independent reflection 3901 
Data / parameters 235 
Goodness-of-fit on F2 0.102 
Final R indices R[F2 > 2σ(F2)] = 0.037 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: ORTEP diagram of 2-phenoxypyrimidine (41)38 
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Treatment of 2-chloropyrimidine (35) with 3-methoxyphenol (42) gave 36% 
yield of colourless crystal (43). The mass spectrum displayed an [M+] peak at m/z 202 
which is consistent with the molecular formula C11H10N2O2. 
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(43) 
The 1H NMR spectrum of (43) also showed similar profile for protons of 
pyrimidine ring of (37). In addition two triplets were observed at δ 7.33 and δ 7.04  with 
coupling constant of 4.6 Hz was assigned to H-5’ and H-2’ respectively. A multiplet at 
δ 6.79 were attributable to H-4’, H-5 and H-6’. The remaining singlet at δ 3.81 indicated 
the presence of a methoxyl.  
 
The 13C NMR spectrum showed a total of 10 signals consist one methoxy, 3 
quaternary and 6 methine representing 11 carbon atoms which agree with the molecular 
formula of (43). Two carbon peaks were similar with compound (37) for C-2 and 
methoxy group. The low intensity of quaternary carbons recorded at δ 160.7 and δ 153.9 
were assigned to C-1’ and C-3’. A signal at δ 158.7 was assigned to C-4/C-6 where as 
five signals at δ 130.0 – δ 100.5 were assigned due to carbon C-5’, C-5, C-6’, C-4’ and 
C-2’. The IR spectrum displayed similar absorption bands as (37) in the earlier 
discussion. 
 
The structure of (43) was also determined by X-ray crystallography analysis. 
The crystal system was found as monoclinic and the refinement data of (43) are as 
shown in Table 3.2 while Figure 3.4 showed the ORTEP diagram of (43). 
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Table 3.2: The crystal system and refinement data of compound (43) 
Crystal data and structure refinement for 2-(3-Methoxyphenoxy)pyrimidine (43) 
Chemical formula  C11H10N2O2 
Molecular weight 202.21 
Crystal system  Monoclinic 
T (K) 293 
Space group Cc 
a = (Å) 8.8120 (16) 
b (Å) 18.215 (3) 
c (Å) 7.2094 (10) 
β (º) 119.380 (2) 
V (Å3) 1008.4 (3) 
Z  4 
Dcalc  Mg m−3 1.332 
Absorption coefficient µ (mm−1) 0.09 
F000   424 
Crystal size (mm) 0.40 × 0.30 × 0.08 
θ range for data collection 2.2–21.9 
Index ranges (−11, −23, −9) to (11, 23, 9) 
Reflections collected 4725 
Independent reflection 1165 
Data / parameters 138 
Goodness-of-fit on F2 0.086 
Final R indices R[F2 > 2σ(F2)] 0.032 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: ORTEP diagram of 2-(3-Methoxyphenoxy)pyrimidine (43)39 
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Colourless crystal of 2-(o-tolyloxy)pyrimidine (45) was obtained when 2-
chloropyrimidine (35) was reacted with o-cresol (44) in 40% yield. The GC-mass 
spectrum displayed an [M+] at m/z 186 which in agreement with the molecular formula 
C11H10N2O 
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(45) 
The 1H NMR spectrum of (45) showed a triplet at δ 7.30 was due to H-3’ and H-
6’. A triplet was also observed at δ 7.19 with coupling constant 6.1 Hz was due to H-4’. 
A doublet and a triplet were observed at δ 7.12 and δ 7.01 which were due to H-5’ and 
H-5 respectively. For proton H-4 and H-6 the doublet peak was similar to compound 
(37).  
 
The 13C NMR spectrum of (45) showed a total of 10 carbon peaks, which consist 
of one methyl, 3 quaternary and 6 methine carbons. One signal for C-2 was similar to 
(37) carbon peak. Signal at δ 159.7 and δ 151.3 were assigned to carbons C-4/C-6 and 
C-1’ while six signals at δ 131.3 - δ 159.7 were due to C-2’, C-3’, C-5’, C-4’, C-6’ and 
C-5. The peak recorded at δ 16.2 was assigned to carbon of methyl group. IR spectrum 
displayed similar absorption bands as compound (37) as discussed earlier. 
 
The structure of (45) was also determined by X-ray crystallography analysis. 
The crystal system was found to be orthorhombic and the refinement data of (45) are as 
shown in Table 3.3 while Figure 3.5 showed the ORTEP diagram of (45). 
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Table 3.3: The crystal system and refinement data of compound (45) 
Crystal data and structure refinement for 2-(o-Tolyloxy)pyrimidine (45) 
Chemical formula  C11H10N2O 
Molecular weight 186.21 
Crystal system  Orthorhombic 
T (K) 153 
Space group Pca21 
a = (Å) 7.5197(2) 
b (Å) 12.7997 (3) 
c (Å) 20.3238 (4) 
V (Å3) 1956.16 (8) 
Z  8 
Dcalc  Mg m−3 1.265 
Absorption coefficient µ (mm−1) 0.08 
F000   784 
Crystal size (mm) 0.35 x 0.25 x 0.15 
θ range for data collection 2.6 – 27.9 
Index ranges (-9,-16, -26) to (9, 16, 26) 
Reflections collected 12792 
Independent reflection 2317 
Data / parameters 255 
Goodness-of-fit on F2 0.088 
Final R indices R[F2 > 2σ(F2)] 0.033 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: ORTEP diagram of 2-(o-tolyloxy)pyrimidine (45)40 
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Reactions of 2-chloropyrimidine (35) with 1,2-dihydroxybenzene (46) gave 25% 
yield of colourless crystal (47). The structure of 2-(pyrimidin-2-yloxy)phenol (47) was 
confirmed by spectroscopic methods. The mass spectrum displayed an [M+] at m/z 188 
which agree with the molecular formula C10H8N2O2. 
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(47) 
The 1H NMR spectrum of (47) showed a singlet at δ 9.55 was assigned to O-H. 
Triplet were also observed on the benzene ring at δ 6.92 and δ 6.80 with coupling 
constant 6.3 Hz and 5.9 Hz respectively were assigned to H-4’ and H-5’. The proton 
peaks for the pyrimidine ring were similar to compound (37).  
The 13C NMR spectrum showed a total of nine carbon peaks consisting three 
quaternary carbons and six methine carbons which agreement with molecular formula 
of (47). The rest of four carbon peaks were similar to the compound (37). Meanwhile 
signals δ 123.1 – δ 116.7 were due to C-3’, C-4’, C-5’ and C-6’.  
 
The IR spectrum displayed a strong absorption bands at 3297 cm-1 which was 
due to OH group. Others displayed absorption bands were similar to (37) as discussed 
earlier. The structure of compound (47) was also determined by X-ray crystallography 
analysis. The crystal system is monoclinic and the refinement data of (47) are as shown 
in Table 3.4 while Figure 3.6 showed the ORTEP diagram of compound (47). 
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Table 3.4: The crystal system and refinement data of compound (47) 
Crystal data and structure refinement for 2-(Pyrimidin-2-yloxy)phenol (47) 
Chemical formula  C10H8N2O2 
molecular weight 188.18 
Crystal system  Monoclinic 
T (K) 293 
Space group C2/c 
a = (Å) 18.0849 (18) 
b (Å) 7.3293 (8) 
c (Å) 13.3983 (14) 
β (º) 92.521 (1)° 
V (Å3) 1774.2 (3) 
Z  8 
Dcalc  Mg m−3 1.409 
Absorption coefficient µ (mm−1) 0.10 
F000   784 
Crystal size (mm) 0.32 × 0.30 × 0.10 
θ range for data collection 3.0–26.9° 
Index ranges (−23, −9, −17) to (23, 9, 15) 
Reflections collected 2048 
Independent reflection 2048 Rint = 0.027 
Data / parameters 130 
Goodness-of-fit on F2 0.112 
Final R indices R[F2 > 2σ(F2)] 0.039 
 
 
 
 
 
 
 
 
 
Figure 3.6: ORTEP diagram of 2-(Pyrimidin-2-yloxy)phenol (47)41 
 
Reactions of 2-chloropyrimidine (35) with m-nitrophenol (48) gave 39 % yield 
of yellow crystals (49). The GC-mass spectrum gave an [M+] at m/z 217 which is 
consistent with the molecular formula C10H7N3O3. 
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(49) 
The 1H NMR spectrum of (49) showed a doublet at δ 8.53 with coupling 
constant 4.9 Hz which was assigned to H-4 and H-6, while a multiplet at δ 8.05 was due 
to H-2’ and H-4’. Another multiplet at δ 7.54 was assigned to H-5’ and H-6. The 
remaining signal is a triplet with coupling constant 4.9 Hz was observed at δ 7.07 which 
was due to H-5.  
 
The 13C NMR spectrum showed a total of 9 signals representing 10 carbons 
which agree with the molecular formula of 2-(3-nitrophenoxy)pyrimidine (49). The 
relative low intensity signal at δ 164.6 was assigned to C-2. A signal at δ 159.9 was 
assigned to carbons C-4, C-5 and C-6. The signals at δ 153.0 and δ 130.2 were due to C-
1’ and C-3’ respectively. Signals δ 128.1 – δ 117.1 were assigned to C-2’, C-5’, C-6’ 
and C-4’. 
 
The IR spectrum displayed similar absorption bands as (37) which have been 
discussed earlier. However, additional band at 1353 cm-1 was due to NO2 group. The 
structure of (49) was also determined by X-ray crystallography analysis. The crystal 
system is orthorhombic and the crystal refinement data of (49) are as shown in Table 
3.5, while Figure 3.7 showed the ORTEP diagram of compound (49). 
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Table 3.5: The crystal system and refinement data of compound (49) 
Crystal data and structure refinement for 3-Nitrophenyl pyrimidin-2-yl ether (49) 
Chemical formula  C10H7N3O3 
Molecular weight 217.19 
Crystal system  Orthorhombic, 
T (K) 118 
Space group Pbcn 
a = (Å) 18.1360 (3) 
b (Å) 7.3355 (1) 
c (Å) 14.5986 (3) 
V (Å3) 1942.15 (6) 
Z  8 
Dcalc  Mg m−3 1.486 
Absorption coefficient µ (mm−1) 0.11 
F000   896 
Crystal size (mm) 0.40 × 0.20 × 0.15 
θ range for data collection 2.8–28.2º 
Index ranges (−23, −9, −18) to (23, 9, 18) 
Reflections collected 12785 
Independent reflection 2242 
Data / parameters 145 
Goodness-of-fit on F2 0.102 
Final R indices R[F2 > 2σ(F2)] 0.037 
 
 
 
 
 
 
 
 
 
Figure 3.7: ORTEP diagram of 3-nitrophenylpyrimidin-2-yl ether (49)42 
 
2-(p-Tolyloxy)pyrimidine (51) was formed when 2-chloropyrimidine (35) was 
treated with p-cresol (50). 33 % yield of colourless crystals was obtained. The GC-mass 
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spectrum gave an [M+] at m/z 186 which is consistent with the molecular formula 
C11H10N2O. 
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(51) 
The 1H NMR spectrum of (51) showed similar signals attributable to H-4/H-6 
and H-5 as of (37), while another doublet with coupling constant 8.8 Hz at δ 7.28 was 
assigned to H-3’ and H-5’. Another doublet (J=6.8 Hz) at δ 6.97 was due to H-3’ and H-
5’. An upfield singlet at δ 2.9 indicated to the presence of methyl group. 
 
The 13C NMR spectrum showed a total of eight signals represent three 
quaternary, seven methine and one methyl carbons which in agreement with the 
molecular formula of (51). The relative low intensity signals at δ 160.6, δ 157.0 and δ 
146.2 were assigned to quaternary carbons C-2, C-1’ and C-4’. The carbons of pyrazine 
ring were recorded at δ 141.0, δ 138.1 and δ 135.7 which were assigned to C-3, C-5 and 
C-6. The signals at δ 122.3 was assigned to C-2’ and C-6’ while a signal at δ 114.8 was 
due to C-5’ and C-3’. Meanwhile a signal at δ 55.6 was due to carbon of a methyl 
group. The IR spectrum of (51) was similar to that of (37) as discussed earlier. 
 
The structure of compound (51) was determined by X-ray crystallography 
method. The crystal system is orthorhombic and the refinement data of (51) are as 
shown in Table 3.6, while Figure 3.8 showed the ORTEP diagram of compound (51). 
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Table 3.6: The crystal system and refinement data of compound (51) 
Crystal data and structure refinement for 2-(p-tolyloxy)pyrimidine (51) 
Chemical formula  C11H10N2O 
Molecular weight 186.21 
Crystal system  Orthorhombic 
T (K) 153 
Space group Pbca 
a  (Å) 11.2918 (2) 
b (Å) 7.2275 (1) 
c (Å) 23.3359 (5) 
V (Å3) 1904.48 (6) 
Z  8 
Dcalc  Mg m−3 1.299 
Absorption coefficient µ (mm−1) 0.09 
F000   784 
Crystal size (mm) 0.35 × 0.35 × 0.35 
θ range for data collection 2.8–28.2 
Index ranges (−14, −9, −30) to (13, 9, 30) 
Reflections collected 12308 
Independent reflection 2189 
Data / parameters 128 
Goodness-of-fit on F2 0.109 
Final R indices R[F2 > 2σ(F2)] 0.038 
 
 
 
 
 
Figure 3.8:  ORTEP diagram of 2-(p-tolyloxy)pyrimidine (51)43 
 
3.2.2 Reactions of 2-chloropyrimidin-4-amine with phenol  
 
Reactions of 2-chloropyrimidin-4-amine (52) with phenol (40) gave 47 % yield 
of colourless crystal of (53). The GC-mass spectrum displayed an [M+] at m/z 217 
which consistent with the molecular formula C10H9N3O 
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(53) 
The 1H NMR spectrum of (53) showed a doublet at δ 8.02 with coupling 
constant of 5.6 Hz was assigned to H-6, while a triplet at δ 7.38 was attributable to H-3’ 
and H-5’. A multiplet was also observed at δ 7.17 which was due to H-2’, H-4’, H-6’, 
while a doublet with coupling constant 5.6 Hz were observed at δ 6.14  was assigned to 
H-5. A broad upfieldsinglet at δ 5.00 indicated the presence of NH2 group. 
 
The carbon peaks of the 13C NMR spectrum showed a total of eight peaks 
representing three quaternary and seven methine carbons which in agreement with the 
molecular formula of (53). The peaks for C-2, C-4 and C-6 were similar to carbon peak 
of compound (37). The signals at δ 153.0 and δ 130.2 were due to C-1’ and C-3’ 
respectively. Signals recorded at δ 128.1 – δ 117.1 were assigned to C-2’, C-5’, C-6’ 
and C-4’. 
 
IR spectrum displayed similar absorption bands to those (37). Strong absorption 
recorded at 3130 cm-1 which was due to NH2- stretching vibration. The structure of 
compound (53) was determined by X-ray crystallography analysis. The crystal system is 
orthorhombic and the refinement data of (53) are as shown in Table 3.7, while Figure 
3.9 showed the ORTEP diagram of compound (53). 
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Table 3.7: The crystal system and refinement data of compound (53) 
Crystal data and structure refinement for 4-Amino-2-phenoxypyrimidine (53) 
Chemical formula  C10H9N3O 
Molecular weight 187.20 
Crystal system  Monoclinic 
T (K) 120 
Space group P21/n 
a = (Å) 8.8443 (3) 
b (Å) 12.1214 (3) 
c (Å) 9.0415 (2) 
β (º) 96.751 (2) 
V (Å3) 962.58 (5) 
Z  4 
Dcalc  Mg m−3 1.292 
Absorption coefficient µ (mm−1) 0.09 
F000   392 
Crystal size (mm) 0.40 × 0.20 × 0.10 
θ range for data collection 2.3–27.9 
Index ranges (−10, −15, −10) to (11, 15, 11) 
Reflections collected 6375 
Independent reflection 2178 
Data / parameters 136 
Goodness-of-fit on F2 0.163 
Final R indices R[F2 > 2σ(F2)] 0.055 
 
 
 
 
 
 
 
 
Figure 3.9:  ORTEP diagram of 4-Amino-2-phenoxypyrimidine (53)44 
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3.3 Synthesis of pyrazine derivatives 
 
Reactions of 2-chloropyrazine (54) with o-methoxyphenol (36) gave 41 % yield 
of colourless crystal of compound (55). The GC-mass spectrum gave an [M+] at m/z 202 
which is consistent with the molecular formula C11H10N2O2 
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(55) 
The 1H NMR spectrum of (55) showed singlets at δ 8.43,  δ 8.22 and δ 8.06 
which were due to H-3, H-5 and H-5 respectively. A doublet at δ 7.23 with coupling 
constant 8.08 Hz, was assigned to H-6’. Another doublet was also recorded at δ 7.16 
with coupling constant 6.6 Hz which was due to H-2’. A triplet with coupling constant 
of 8.28 Hz was recorded at δ 7.03 which was due to H-3’and H-4’.  
 
The 13C NMR spectrum showed a total of eleven signals which consist of three 
quaternary, seven methine and one methoxy carbons which in agreement with the 
molecular formula of (55). The relative low intensity signals recorded at δ 160.1, δ 
151.5 and δ 141.5 were assigned to C-2, C-2’ and C-1’respectively. Signals at δ 141.0, δ 
138.1 and δ 135.2 were assigned to C-6, C-3 and C-5 of the pyrazine ring. Meanwhile, 
signals at δ 126.7, δ 122.9,  δ 121.1 and δ 112.8 were due to C-4,’, C-6’, C-5’ and C-3’ 
respectively. One upfield signal at δ 55.7 was due to a methoxy carbon. The IR 
spectrum displayed similar absorption bands as compared to (37). 
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2-(4-Methoxyphenoxy)pyrazine (56) was obtained in 42% as colorless crystal 
when 2-chloropyrazine (54) was reacted with p-methoxyphenol (38). The GC-mass 
spectrum displayed an [M+] at m/z 202 which is consistent with the molecular formula 
C11H10N2O2 
N
N
O
5
6
6'
5' 3'
4'
2
3
2'
O
 
(56) 
The 1H NMR spectrum of (56) showed similar protons profiles for pyrazine as 
compared to (55). In addition, a doublet (J= 10.5 Hz) at δ 7.10 was attributable to H-3’ 
and H-5’. Another doublet was also observed with coupling constant 6.8 Hz at δ 6.97 
which was due to H-2’ and H-6’.  
 
The 13C NMR spectrum showed a total of nine which representing peaks three 
quaternary, seven methine carbons and one methoxy carbons which in agreement with 
the molecular formula of (56). The relative low intensity signals recorded at δ 160.6, δ 
157.0 and δ 146.2 were assigned to C-2, C-4’ and C-1’ respectively. The methine 
carbons of pyrazine ring were recorded δ 141.0, δ 138.1 and δ 135.7 which was 
assigned to C-6, C-5 and C-3 respectively. The signals at δ 122.3 was attributable to C-
2’ and C-6’ while a signal at δ 114.8, was assigned to C-5’ and C-3’. Meanwhile, signal 
at δ 55.6 was due to the methoxy carbon. IR spectrum displayed similar absorption 
bands ac compared to those of (37) as discussed earlier. 
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The structure of (56) was also determined by X-ray crystallography analysis. 
The crystal system is monoclinic and the refinement data of (56) are as shown in Table 
3.8, while Figure 3.10 showed the ORTEP diagram of compound (56). 
 
Table 3.8: The crystal system and refinement data of compound (56) 
Crystal data and structure refinement for 2-(4-methoxyphenoxy)pyrazine (56) 
Chemical formula  C11H10N2O2 
Molecular weight 202.21 
Crystal system  Monoclinic 
T (K) 293 
Space group P21/c 
a = (Å) 5.8783 (2) 
b (Å) 10.9298 (4) 
c (Å) 15.6430 (6) 
β (º) 97.109 (2) 
V (Å3) 997.32 (6) 
Z  4 
Dcalc  Mg m−3 1.347 
Absorption coefficient µ (mm−1) 0.10 
F000   424 
Crystal size (mm) 0.35 × 0.20 × 0.10 
θ range for data collection 2.3–22.4 
Index ranges (−6, −12, −18) to (6, 12, 18) 
Reflections collected 5515 
Independent reflection 1743 
Data / parameters 138 
Goodness-of-fit on F2 0.100 
Final R indices R[F2 > 2σ(F2)] 0.036 
 
 
 
 
 
 
 
Figure 3.10:  ORTEP diagram 2-(4-Methoxyphenoxy)pyrazine (56)45 
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3.4  Fluorescence characteristics of synthesised compounds 
 
Figure 3.11 shows a histogram of the fluorescence intensity of 2-(2-
methoxyphenoxy)pyrimidine (37),  2-(4-methoxyphenoxy)pyrimidine (39), 2-
phenoxypyrimidine (41), 2-(3-methoxyphenoxy)pyrimidine (43), 2-(o-
tolyloxy)pyrimidine (45), 2-(pyrimidin-2-yloxy)phenol (47), 2-(3-
nitrophenoxy)pyrimidine (49), 2-(p-tolyloxy)pyrimidine (51), 2-phenoxypyrimidin-4-
amine (53), 2-(2-methoxyphenoxy)pyrazine  (55), and 2-(4-methoxyphenoxy)pyrazine 
(56) in various of solvents. 
 
Figure 3.11: Fluorescence characteristic of synthesis compound in various                                              
solvents 
 
 
Table 3.9 shows the fluorescence characteristic of 2-(2-
methoxyphenoxy)pyrazine (55) and 2-(4-methoxyphenoxy)pyrazine (56) in various 
solvents in capped conditions.  
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Table 3.9: Fluorescence characteristic of 2-(2-methoxyphenoxy)pyrazine (55) 
and 2-(4-methoxyphenoxy)pyrazine (56) in various solvents. 
(concentration: 4.95 x 10-4 M) 
 
Compound Solvent Excitation 
wavelength 
(nm) 
Fluorescence 
wavelength 
(nm) 
Intensity 
Hexane 345 355 215.63 
Ethanol 214 362 3.71 
Acetonitrile 203 325 45.14 
Ethyl acetate 344 437 130.55 
2-(2-
methoxyphenoxy)pyrazine 
(55) 
Tetrahydrofuran 203 333 21.60 
Hexane 349 377 283.47 
Ethanol 200 376 13.95 
Acetonitrile 201 347 37.05 
Ethyl acetate 347 446 100.07 
2-(4-
methoxyphenoxy)pyrazine 
(56) 
Tetrahydrofuran 204 373 46.35 
 
 
 
 
Figure 3.12: Fluorescence characteristic of compound (55) and (56) in various 
solvents. 
 
The fluorescence characteristic of the compounds (55) and (56) were carried out 
in hexane, ethanol, acetonitrile, ethyl acetate and tetrahydrofuran as show in Figure 
3.12. Compounds (55) and (56) showed the lowest fluorescence intensities in ethanol. 
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The reason of low fluorescence intensity observed is due to solvent effects whereby it is 
believed that compound (55) and (56) formed a complex with the ethanol as shown in 
Figure 3.13.  
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Formation of hydrogen bonded complexes 
 
 
The formation of hydrogen bonds which is capable of conjugating with the pi-
electron hence been disturbed and caused the fluorescence intensity to be reduced. This 
phenomenon favours the low lying n → pi* transitions which refers to the excitation of a 
nonbonding electron to an antibonding orbital. It was reported that n → pi* transition46 
is forbidden  in fluorescence spectra and when it present the intensity is weak. As a 
result, a decrease in fluorescence intensity was observed. 
 
A change in the ability of a solvent to form hydrogen bonds can affect the nature 
of n → pi* and pi → pi* of the lowest singlet state. Inversion of these two states can be 
observed when the polarity and the hydrogen-bonding power of the solvent increases, 
because the n → pi* state shifts to higher energy whereas the pi → pi* state shifts to 
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lower energy. This results in decrease fluorescence intensity because radiative emission 
from n → pi* states is known to be less efficient than from pi → pi* states.  
 
However in Figure 3.12, compounds (55) and (56) exhibit at the highest 
fluorescence intensity in hexane which is a non-polar solvent. It is believe that the 
occurrence of an electronic transition in a solute requires a finite transition dipole which 
polarizes the surrounding solvent shell.47 As a result high fluorescence intensity was 
observed. 
 
Table 3.10 shows the fluorescence characteristic of 2-(2-
methoxyphenoxy)pyrimidine (37), 2-(4-methoxyphenoxy)pyrimidine (39), 2-(2-
methoxyphenoxy)pyrazine (55) , and  2-(4-methoxyphenoxy)pyrazine (56) in various 
solvents in capped condition.  
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Table 3.10: Fluorescence characteristic of 2-(2-methoxyphenoxy)pyrimidine (37), 
2-(4-methoxyphenoxy)pyrimidine (39), 2-(2-methoxyphenoxy)pyrazine 
(55), and 2-(4-methoxyphenoxy)pyrazine (56) in various solvents in 
capped condition. (Concentration: 4.95 x 10-4 M) 
 
Compound Solvent Excitation 
wavelength 
(nm) 
Fluorescence 
wavelength 
(nm) 
Intensity 
ethanol 201 388 61.91 
acetonitrile 203 323 469.05 
2-(4-
methoxyphenoxy)pyrimidine 
(39) 
tetrahydrofuran 207 380 149.08 
ethanol 260 312 43.99 
acetonitrile 201 355 50.97 
2-(2-
methoxyphenoxy)pyrimidine 
(37) 
tetrahydrofuran 203 389 41.57 
ethanol 214 359 2.70 
acetonitrile 203 361 49.61 
2-(2-
methoxyphenoxy)pyrazine
 (55) 
tetrahydrofuran 203 381 18.78 
ethanol 200 377 12.15 
acetonitrile 201 379 31.65 
2-(4-
methoxyphenoxy)pyrazine 
(56) 
 
tetrahydrofuran 204 401 37.68 
 
Figure 3.14 and Figure 3.15 show the histogram of fluorescence intensity 
between phenoxypyrimidines and phenoxypyrazines respectively.   
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Figure 3.14: Fluorescence of 2-(4-methoxyphenoxy)pyrimidine (39) and 2-(4-
methoxyphenoxy)pyrazine (56) in ethanol, acetonitrile and 
tetrahydrofuran. 
 
 
 
 
Figure 3.15: Fluorescence of 2-(2-methoxyphenoxy)pyrimidine (37) and 2-(2-
methoxyphenoxy)pyrazine (55) in ethanol, acetonitrile and 
tetrahydrofuran. 
 
 
2-(4-Methoxyphenoxy)pyrimidine (39) gave higher fluorescence intensity than 
2-(4-methoxyphenoxy)pyrazine (56) in ethanol, acetonitrile and tetrahydrofuran 
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respectively as shown in Figure 3.14. The same pattern observed for 2-(2-
methoxyphenoxy)pyrimidine (37) and 2-(2-methoxyphenoxy)pyrazine (55). From 
the results obtained, 1, 3 methoxyphenoxydiazine derivatives gave a higher fluorescence 
intensity than 1, 4 methoxyphenoxydiazine i.e pyrazine derivatives. 
 
The possible explanation for this result might be due to the position of the 
nitrogen atoms in the heterocyclic ring as shown in Figure 3.16. In pyrimidine, oxygen 
atom binds to carbon which is ortho to two nitrogen atoms of pyrimidine ring. Since 
oxygen is an electron donor, thus it activated both ortho nitrogen atoms of pyrimidine. 
On the other hand, in pyrazine, the oxygen is bind to carbon which is meta and ortho  to 
nitrogen atoms of pyrazine ring. Thus, the position of nitrogen atoms in the ring plays 
an important factor to be considered in studying the fluorescence behavior of organic 
compounds. 
  
 
 
Figure 3.16: The position of the nitrogen atoms in compound (37) and (55) 
 
 
 
 
Table 3.10 also shows compound (39) gave a higher fluorescence intensity than 
compound (37). The low fluorescence intensity recorded for compound (37) is possibly 
due to interference between the solvent and the ortho methoxy substituent as shown in 
Figure 3.17. This interference can result in the steric hindrance, and such interference 
did not occur in compound (39). The steric hindrance created by the ortho methoxy 
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group enhanced by the formation of hydrogen bonding with the solvent as shown in 
Figure 3.17.48 
Fig
ure 3.17: Steric hindrance effect by ortho and para methoxy substituent 
 
Similar observations were recorded for compounds (55) and (56), except when 
acetonitrile was used as the solvent. Different observation with acetonitrile was due to 
the non-hydrogen bonding character of acetonitrile. 
 
In order to support the previous result on the steric hindrance effect, 2-(o-
tolyloxy)pyrimidine (45) and 2-(p-tolyloxy)pyrimidine (51) were synthesized. The 
fluorescence characteristics of (45) and (51) were as shown in Table 3.11 and Figure 
3.18. 
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Table 3.11: Fluorescence characteristic of 2-(o-tolyloxy)pyrimidine (45) and 2-(p-
tolyloxy)pyrimidine (51) in ethyl acetate and acetonitrile in capped 
condition. (concentration: 5.376 x 10-4 M) 
 
Compound Solvent Excitation 
wavelength 
(nm) 
Fluorescence 
wavelength 
(nm) 
Intensity 
Ethyl acetate 210 351 13.51 2-(o-tolyloxy)pyrimidine 
(45) 
acetonitrile 205 389 15.88 
Ethyl acetate 200 358 35.31 2-(p-tolyloxy)pyrimidine 
(51)  
 acetonitrile 204 366 29.67 
 
 
Figure 3.18: Fluorescence characteristic of 2-(p-tolyloxy)pyrimidine (51) and 2-(o-
tolyloxy)pyrimidine (45) in ethyl acetate and acetonitrile in capped 
condition.  
 
It can be seen from Table 3.11 and Figure 3.18 that compound (51) showed 
higher fluorescence intensity than compound (45) in ethyl acetate and acetonitrile. Thus 
the observation is in the agreement with previously recorded for compounds (37) and 
(39). 
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Table 3.12 and Figure 3.19 show fluorescence characteristics of 2-(p-
methoxyphenoxy)pyrimidine (39) and 2-(m-methoxyphenoxy)pyrimidine (43) in 
various of solvents. Compound (39) showed a higher fluorescence intensity compare to 
compound (43).  
 
 
Table 3.12: Fluorescence characteristic of 2-(4-methoxyphenoxy)pyrimidine (39) 
and 2-(3-methoxyphenoxy)pyrimidine (43) in various solvents in 
capped condition. (concentration: 4.95 x 10-4 M) 
 
Compound Solvent Excitation 
wavelength 
(nm) 
Fluorescence 
wavelength 
(nm) 
Intensity 
Hexane 350 380 95.38 
Ethanol 201 388 61.91 
Acetonitrile 203 323 469.05 
Ethyl acetate 204 392 130.11 
2-(4-
methoxyphenoxy)pyrimidine 
(39) 
Tetrahydrofuran 207 380 149.08 
Hexane 201 359 59.55 
Ethanol 213 379 15.04 
Acetonitrile 204 364 10.39 
Ethyl acetate 209 349 28.84 
2-(3-
methoxyphenoxy)pyrimidine 
(43) 
Tetrahydrofuran 202 344 61.83 
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Figure 3.19:  Fluorescence characteristic of 2-(4-methoxyphenoxy)pyrimidine (39) 
and 2-(3-methoxyphenoxy)pyrimidine (43) in various solvents in 
capped condition.  
 
 
It seems that methoxyphenoxypyrimidine with a para substituent gave a higher 
fluorescence intensity than with meta substituent. As shown in Figure 3.20, the methoxy 
group which is an electron donating at the para position, is more effective at 
transferring electron to the pyrimidine ring which in turn increasing its hydrogen-bond 
basicity and retention, i.e para methoxy group has more negative value of the Hammet 
σ-parameter49 than does a meta methoxy group. As the result, compound (39) gave 
higher fluorescence intensity than compound (43).    
 
Figure 3.20: Para position is more effective than meta position in 
transferring electron to the pyrimidine ring 
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Apart from the effectiveness in transferring electron to pyrimidine system, a 
resonance electron-donating engenders partial negative charge at position ortho and 
para to itself as shown in Figure 3.21. The para charge stabilized a positive charge at 
the pyrimidine ring.50 But the resonance effect of a meta methoxy is very much less 
compared to para position, thus meta methoxy in compound (43) gave low fluorescence 
intensity.   
 
 
 
 
 
 
 
 
Figure 3.21: Resonance effect at para and meta position 
 
 
Table 3.13 and Figure 3.22 show the fluorescence characteristic of 2-
phenoxypyrimidin-4-amine (53) and 2-phenoxypyrimidine (41) in various of solvents. 
2-Phenoxypyrimidin-4-amine (53) shows a higher fluorescence intensity than 2-
phenoxypyrimidine (41) in ethanol, acetonitrile, tetrahydrofuran, hexane and ethyl 
acetate respectively.  
 
 
 
H3CO H3CO
N
N
O
resonance effect at para position resonance effect at meta position
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Table 3.13: Fluorescence characteristic of 2-phenoxypyrimidin-4-amine (53) 
(5.348 x 10-4 M) and 2-phenoxypyrimidine (41) (5.814 x 10-4 M) in 
various of solvents. 
 
Compound Solvent Excitation 
wavelength 
(nm) 
Fluorescence 
wavelength 
(nm) 
Intensity 
Hexane 340 366 75.41 
Ethanol 201 381 16.61 
Acetonitrile 205 370 53.75 
Ethyl acetate 201 362 59.53 
2-phenoxypyrimidine 
(41) 
tetrahydrofuran 345 369 111.00 
Hexane 203 358 274.44 
Ethanol 328 360 916.56 
Acetonitrile 212 372 431.18 
Ethyl acetate 204 324 830.94 
2-phenoxypyrimidin-4-
amine (53) 
tetrahydrofuran 226 332 274.35 
 
 
 
Figure 3.22:  Fluorescence characteristic of 2-phenoxypyrimidine (41) and 2-
phenoxypyrimidin-4-amine (53) in various of solvents. 
 
 
In this study, most of the synthesised compounds do not have any substituent on 
the diazine ring. However, only compound (53) has an amino substituent on the 
pyrimidine ring. Generally, heterocyclic compound is electron-riched compound. The 
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presence of amino substituent, which is a very strong electron donating group gave a 
very significant result in fluorescence intensity in comparison with compound (41). 
 
Figure 3.22 shows compound (53) has higher fluorescence intensity than 
compound (41). This observation is due to the hyperchromic effect, which leads to an 
increase in emission intensity. The introduction of an amino group as auxochrome in 
compound (53) causes the hyperchromic shift.51  
 
The pi→pi* transition of polar compound (53) are shifted to longer wavelengths 
and generally towards higher intensity with an increase in solvent polarity. The excited 
state in this transition is more polar than the ground state. The dipole-dipole interaction 
with polar solvent lowers the energy of the excited state. Thus, there is a bathochromic 
shift on-going from hexane (358 nm) to acetonitrile (372 nm) as a result of increasing 
solvent polarity as shown in Table 3.13. 
 
High fluorescence intensity which was recorded for 2-phenoxypyrimidin-4-
amine (53) as compared to 2-phenoxypyrimidine (41) is may also due to the effect of 
twisted intramolecular charge transfer (TICT).52 In ground state, (53) is believed to be 
planar, thus the conjugation between the amino group and the pyrimidine ring is at a 
maximum. This geometry is retained in the excited states. However, there is also a 
special excited state in which the amino group is twisted at a right angle so that 
conjugation is totally lost in this TICT state, thus there is total charge separation 
between the amino group and the pyrimidine ring as shown in Figure 3.23. 
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Figure 3.23:  Twisted Intramolecular Charge Transfer (TICT) effect on 
compound (53)  
 
 
The TICT state cannot be reached by direct light absorption since its geometry is 
totally different from that of ground state. It was formed by the ‘slow’ twisting of the 
two parts of the molecule from planar S1 state. The TICT state has large dipole moment. 
Electrostatic interaction between the molecular dipole moment and polar solvents 
stabilize the twisted form and new emission with high intensity appears which is not 
observed in non-polar solvent.   
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Table 3.14: Fluorescence characteristic of 2-(3-methoxyphenoxy)pyrimidine (43) 
(4.95 x 10-4 M) and 2-(3- nitrophenoxy)pyrimidine (49) (4.608 x 10-4 
M) in various solvents. 
 
Compound Solvent Excitation 
wavelength 
(nm) 
Fluorescence 
wavelength 
(nm) 
Intensity 
Hexane 201 359 59.55 
Ethanol 213 379 15.04 
Acetonitrile 204 364 10.39 
Ethyl acetate 209 349 16.69 
2-(3-
methoxyphenoxy)pyrimidine 
(43) 
tetrahydrofuran 202 344 61.83 
Hexane 205 382 6.34 
Ethanol 382 398 8.72 
Acetonitrile X X X 
Ethyl acetate 208 352 5.73 
2-(3- nitrophenoxy)pyrimidine 
(49) 
tetrahydrofuran 205 404 25.41 
X = not fluorescent 
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Figure 3.24: Fluorescence characteristic of 2-(3-methoxyphenoxy)pyrimidine (43) 
and 2-(3- nitrophenoxy)pyrimidine (49) in various solvents. 
 
Table 3.14 and Figure 3.24 show fluorescence intensity 2-(3-
methoxyphenoxy)pyrimidine (43) and 2-(3-nitrophenoxy)pyrimidine  (49) in various 
solvents. Compound (43) showed a high fluorescence intensity in all solvents whilst 
compound (49) showed low fluorescence intensities in all solvents.  
 
In general, substitution with electron-donating groups induces an increase in the 
molar absorption coefficient and shift in both absorption and fluorescence spectra. The 
presence of lone pairs of electrons on the oxygen and nitrogen atoms does not change 
the pi → pi* nature of the transitions of the parent molecule. These lone pairs are indeed 
involved directly in pi bonding with the aromatic system. 
 
 Compound (43) gave a high fluorescence intensity which is believed to be due to 
the hyperchromic shift.53 The introduction of the auxochromes, 54 i.e methoxy group, 
leads to an increase in intensity.  Other than that, methoxy group which is an electron 
donating group observed enhances the electron density of the aromatic system hence, 
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high intensity is observed. Low fluorescence intensity was observed with compound 
(49) is due to hypochromic effect. The presence of a nitro group, an electron 
withdrawing in compound (49) distorted the chromophore by forcing the rings out of 
coplanarity resulting in the loss of conjugation.  
 
Table 3.15 and Figure 3.25 show fluorescence characteristic of compound (35), 
(37), (45) and (47) in various solvents. Compound (37) showed the highest fluorescence 
intensity followed by compound (47) and compound (45) showed the lowest 
fluorescence intensity. The entire compounds showed this pattern in ethanol, 
acetonitrile and ethyl acetate. 
 
Table 3.15: Fluorescence characteristic of 2-chloropyrimidine (35) (8.772 x 10-4 M), 
2-(o-tolyloxy)pyrimidine (44) (5.3763 x 10-4 M), 2-(2- 
methoxyphenoxy)pyrimidine (46) (4.95 x 10-4 M), and 2-(pyrimidin-2-
yloxy)phenol (48) (5.3191 x 10-4 M)  in various solvents. 
 
Compound Solvent Excitation 
wavelength 
(nm) 
Fluorescence 
wavelength 
(nm) 
Intensity 
Hexane 204 327 103.58 
Ethanol 205 370 460.50 
Acetonitrile 225 363 587.71 
Ethyl acetate 206 370 460.50 
2-chloropyrimidine (35) 
tetrahydrofuran 203 364 29.43 
Hexane 326 358 79.94 
Ethanol 260 312 43.99 
Acetonitrile 201 316 75.67 
Ethyl acetate 210 327 7.96 
2-(2- 
methoxyphenoxy)pyrimidine 
(37) 
tetrahydrofuran 203 340 75.37 
Hexane 324 361 66.52 
Ethanol 207 328 12.70 
Acetonitrile 205 318 32.98 
Ethyl acetate 210 313 31.81 
2-(o-tolyloxy)pyrimidine 
(45) 
tetrahydrofuran 202 331 124.93 
Hexane 201 359 92.87 
Ethanol 200 352 29.00 
Acetonitrile 202 357 96.78 
Ethyl acetate 201 322 191.87 
2-(pyrimidin-2-yloxy)phenol 
(47) 
tetrahydrofuran 208 349 70.26 
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Figure 3.25: Fluorescence characteristic of 2-(2- methoxyphenoxy)pyrimidine 
(37), 2-(o-tolyloxy)pyrimidine (45), and 2-(pyrimidin-2-yloxy)phenol 
(47) in various solvents. 
 
 
 
 
 
Figure 3.26: Bathochromic shift between 2-chloropyrimidine (35) (8.772 x 10-4 M) 
and 2-(o-tolyloxy)pyrimidine (45) (5.3763 x 10-4 M) in hexane. 
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Figure 3.26 showed a bathochromic shift occurred between 2-chloropyrimidine 
(35) and 2-(tolyloxy)pyrimidine (45). This is due to the presence of an auxochrome 
which generally increases the value of excitation by extending the conjugation through 
resonance. This phenomena is also called ‘colour enhancing groups’. 55 
 
The combination of chromophore and auxochrome sometimes behaves as a new 
chromophore having different values of emission maximum. Table 3.15 shows (35) in 
hexane shows emission wavelength at 327 nm whereas compounds (37), (45), and (47) 
show emissions wavelengths of 361 nm, 358 nm and 359 nm respectively. The shift of 
emission wavelength to a longer wavelength is due to a bathochromic shift.56 The 
increase in the wavelengths proves that -OCH3, -OH and -CH3 substituents each as 
auxochrome which extends the conjugation, hence resulting in the increase values of 
emission wavelength.  
 
This finding is supported by the work of Kiss, Molnar and Sandorfy, who have 
pointed out that the magnitude of the shift in the absorption bands produced by 
methoxy, hydroxyl and methyl substituents may correlated with the degree of 
conjugation of these groups.57  
 
The effects of auxochrome on the fluorescence of the synthesised compound are 
listed in Table 3.15. There are exceptions to this table since a number of other factors 
must be considered. For example, molecules which are able to rotate, bend or twist have 
a tendency to lose energy from the excited state through molecular collision and other 
vibration processes. It is not possible to complete set rules for determining whether a 
molecule will fluoresce, as there are many anomalies to be considered. 
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Table 3.16 shows the fluorescence characteristic of compound (37), (41), (55) 
and (56) with time in THF. The measurements were taken immediately, 30 minutes and 
60 minutes. 
 
Table 3.16: Fluorescence characteristic of selected diazine derivatives with time 
in THF 
 
Compound Duration Excitation 
Wavelength 
(nm) 
Fluorescence 
Wavelenghth 
(nm) 
Intensity 
Immediately 359 49.91 
30 358 45.21 
2-(2-
methoxyphenoxy)pyrimidine 
(37) 
60 
310 
 
358 41.24 
Immediately 437 75.84 
30 437 73.6 
2-(2-
methoxyphenoxy)pyrazine 
(55) 
60 
316 
 
436 71.46 
Immediately 452 67.04 
30 450 63.01 
2-(4-
methoxyphenoxy)pyrazine 
(56) 
60 
325 
 
451 58.82 
Immediately 438 20.81 
30 439 20.28 
2-phenoxypyrimidine (41) 
60 
389 
 
439 19.46 
 
 
The study on the possible delayed fluorescence was carried out by measuring the 
fluorescence characteristic of the selected compounds in capped condition with time. 
Four compounds i.e compounds (37), (41), (55), and (56) were selected. The 
fluorescence measurements of these compounds were carried out immediately, after 30 
minutes and after 60 minutes respectively as shown in Table 3.16  
 
2-(2-Methoxyphenoxy)pyrimidine (37) and 2-(4-methoxyphenoxy)pyrazine (56) 
showed a decrease in fluorescence intensity with time as shown in Figure 3.27 and 
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Figure 3.28.  Similar pattern was observed with compounds (41) and (55) as shown in 
Figures 3.29 and 3.30.  
 
 
 
Figure 3.27: Fluorescence spectra of 2-(2-methoxyphenoxy)pyrimidine (37) in 
different time in tetrahydrofuran (4.9505 x 10-4 M) 
 
 
 
 
 
 
Figure 3.28: Fluorescence spectra of 2-(4-methoxyphenoxy)pyrazine (56) in 
different time in tetrahydrofuran (4.9505 x 10-4 M) 
 
 
78 
 
 
 
Figure 3.29: Fluorescence spectra of 2-(2-methoxyphenoxy)pyrazine (55) in 
different time in tetrahydrofuran (4.9505x 10-4 M) 
 
 
 
Figure 3.30: Fluorescence spectra of 2-phenoxypyrimidine (41) in different time 
in tetrahydrofuran (3.8314 x 10-4 M) 
 
In liquid solutions, quenching of excited-singlet states of organic molecules by 
dissolved O2 molecule has a very large diffusion co-efficient. As the solution was 
allowed to stand for 30 and 60 minutes, more oxygen entered in the solution and 
quenched the fluorescence further. 
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In this study, it is possible that ‘chemical’ quenching also occurred through the 
formation of a complex between solute and oxygen. Under atmospheric pressure, the 
concentration of oxygen in most solvents is 10-3 – 10-4 mol L-1.58  
  
Another possible explanation for the reduction of fluorescence intensity with 
time is the formation of a complex between oxygen and the ground state of the organic 
compound as the solution was allowed to stand for a certain period of time. When the 
emission process happened, the oxygen complex may enhance S1 → S0 internal 
conversion hence quenched the fluorescence intensity.   Tables 3.17, 3.18 and 3.19 
show fluorescence characteristics of 2-(pyrimidin-2-yloxy)phenol  (47), 2-
phenoxypyrimidine (41) and 2-(4-methoxyphenoxy)pyrimidine (39) with different 
concentrations. 
 
Table 3.17: Fluorescence characteristic of 2-(pyrimidin-2-yloxy)phenol (47) in 
different concentrations 
 
Solvent  Excitation wavelength 
(nm) 
Fluorescence 
wavelength (nm) 
Intensity 
 10-4 M 10-5 M 10-6 M 10-4 M 10-5 M 10-6 M 10-4 M 10-5 M 10-6 M 
Hexane 201 202 X 360 349 X 91.63 162.78 X 
EtOH 200 X X 352 X X 24.42 X X 
CH3CN 202 202 X 356 356 X 91.73 25.14 X 
EtOAc 201 201 201 377 381 X 182.77 43.37 X 
THF 208 208 208 348 353 367 69.30 34.43 17.53 
Concentration = 5.3191 x 10m M, where 10m M = 10-6 M, 10-5 M, 10-4 M 
X = non-fluorescent 
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Table 3.18: Fluorescence characteristic of 2-phenoxypyrimidine (41) in different 
concentrations 
 
Solvent  Excitation wavelength 
(nm) 
Fluorescence wavelength 
(nm) 
Intensity 
 10-4 M 10-5 M 10-6 M 10-4 M 10-5 M 10-6 M 10-4 
M 
10-5 M 10-6 M 
Hexane 340 X X 366 X X 75.41 X X 
EtOH 201 201 201 381 374 358 16.61 31.66 67.07 
CH3CN 205 204 205 370 362 354 53.75 35.07 30.88 
EtOAc 201 201 203 362 362 375 59.53 32.29 11.68 
THF 345 344 345 369 353 X 111.00 77.07 X 
Concentration = 3.8314 x 10m M, where 10m M = 10-6 M, 10-5 M, 10-4 M 
X = non-fluorescent 
 
Table 3.19: Fluorescence characteristic of 2-(4-methoxyphenoxy)pyrimidine (39) 
in different concentrations 
 
Solvent  Excitation wavelength 
(nm) 
Fluorescence 
wavelength (nm) 
Intensity 
 10-4 M 10-5 M 10-6 M 10-4 M 10-5 M 10-6 M 10-4 M 10-5 M 10-6 M 
Hexane 350 X X 380 X X 95.38 X X 
EtOH 201 202 201 388 381 X 61.91 35.00 X 
CH3CN 203 202 203 323 318 313 469.05 213.77 69.30 
EtOAc 204 204 X 392 384 X 130.11 41.31 X 
THF 207 X X 380 X X 149.08 X X 
Concentration = 4.9505 x 10m M, where 10m M = 10-6 M, 10-5 M, 10-4 M 
X = non-fluorescent 
 
 
 
 Figure 3.31, 3.32 and 3.33 show fluorescence spectra of compounds (39), (41) 
and (47) at different concentrations. 
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Figure 3.31: Fluorescence spectra of 2-(4-methoxyphenoxy)pyrimidine (39) in 
different concentration in acetonitrile 
 
 
 
Figure 3.32: Fluorescence spectra of 2-phenoxypyrimidine (41) in different 
concentration in acetonitrile 
 
 
 
4.9505 x 10-6 M 
4.9505 x 10-5 M 
4.9505 x 10-4 M 
3.8314 x 10-6 M 
3.8314 x 10-5 M 
3.8314 x 10-4 M 
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Figure 3.33:  Fluorescence spectra of 2-(pyrimidin-2-yloxy)phenol (47) in different 
concentration in tetrahydrofuran 
 
It has been reported that the fluorescence intensity of a given solute increases 
linearly with increasing concentration at relatively low concentration. At higher 
concentrations the fluorescence intensity reached a limiting value and even decrease 
with further increase in concentration. Several processes are responsible for these 
“concentration-quenching” effects. This is believed what happens to compounds (39), 
(41) and (47) as shown in Figure 3.31, Figure 3.32 and Figure 3.33. 
  
 At higher concentrations, the fluorescence intensity of all compounds may 
reached a limiting value and resulted in concentration quenching which decreased with 
further increases in concentration.  
 
This is because the low-frequency tail of the absorption spectrum of the 
compounds often overlaps with the high-frequency end of its fluorescence spectrum, 
thus fluorescence from electronic excited state molecule can be re-absorbed by a 
ground-state molecule of the same solute. The probability of such an event increases 
with increasing of solute concentration. “Self-absorption” distorted the shape of the 
5.3191 x 10-4 M 
5.3191 x 10-6 M 
5.3191 x 10-5 M 
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fluorescence spectrum, since only the higher frequencies in the spectrum are re-
absorbed. Self-absorption ultimately reduced the fluorescence intensity. 
 
The change of pH also affects the fluorescence intensity of the compounds 
studied. Selected data on fluorescence maxima and intensity with pH of the selected 
compounds are as summarized in Table 3.20 while their spectra in ethanol are shown in 
Figure 3.34 and Figure 3.35. 
 
Table 3.20: Fluorescence characteristic of 2-phenoxypyrimidine (41) and 2-(3-
methoxyphenoxy)pyrimidine (43)  with variation of pH in ethanol 
 
Compound pH Excitation 
wavelength 
(nm) 
Fluorescence 
wavelength 
(nm) 
Intensity 
2 264 346 16.67 
3 206 355 67.29 
7 206 362 108.18 
11 201 360 129.34 
2-phenoxypyrimidine (41) 
12 201 365 192.43 
2 201 365 130.32 
3 202 365 137.58 
7 202 363 170.88 
11 201 381 237.91 
2-(3-
methoxyphenoxy)pyrimidine 
(43) 
12 202 365 365.48 
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Figure 3.34: Fluorescence spectra of 2-(3-methoxyphenoxy)pyrimidine (43) with 
variation of pH in ethanol 
 
 
Figure 3.35: Fluorescence spectra of 2-phenoxypyrimidine (41) with variation of 
pH in ethanol 
 
The fluorescence spectra for 2-phenoxypyrimidine (41) and 2-(3-
methoxyphenoxy)pyrimidine (43)  were measured in ethanol under neutral, acidic (0.1 
M HCl) and basic (0.1 M NaOH) conditions. Table 3.20 shows that the fluorescence 
intensity increases with increases pH. The low fluorescence intensity observed in acidic 
medium is probably due to protonation of the compound. The protonated compound 
pH 11 
pH 7 
pH 3 
pH 2 
pH 12 
pH12 
pH11 
pH7 
pH2 
pH3 
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shows lower fluorescence intensity because it involves the transferring of electron to the 
phenoxy ring as shown in Figure 3.36 and Figure 3.37. 
 
 
Figure 3.36: The electron transfer to the ring phenoxy of 2-(3- 
methoxyphenoxy)pyrimidine (43) 
 
 
 
Figure 3.37: The electron transfer to the ring phenoxy of 2-phenoxypyrimidine 
(41) 
 
 As a result, the fluorescence intensity is completely quenched. The 
corresponding electrons phenomena created a non-conjugated system which resulting in 
non-fluorescent compounds.  
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CHAPTER 4:  CONCLUSION 
 
 
 The objective of this study is to synthesize series of phenoxy derivatives of 
pyrimidine and pyrazine which then followed by the study of fluorescence characteristic 
of the synthesized compounds were successful. The NMR, IR and GC-MS analysis 
were carried out to confirm the structure of the synthesised compounds. Fluorescence 
studies shows a complete change in the intensity with a change of solvent, e.g. 
acetonitrile, ethanol, tetrahydrofuran, hexane and ethyl acetate. 
 
 2-Phenoxypyrimidin-4-amine (53) shows higher intensity than 2-
phenoxypyrimidine (41). The higher intensity observed was due to the presence of 
electron donating group on the pyrimidine ring. In the case of 2-(2-
methoxyphenoxy)pyrimidine (37) and 2-(4-methoxyphenoxy)pyrimidine (39), the 
fluorescence peak in compound (37) is lower than compound (39). The steric hindrance 
effect in compound (37) is believed to be the reason of the low fluorescence intensity 
recorded.  
 
 While in case of concentration, the fluorescence intensity found to be increased 
with increasing concentration at 10-4 M. Studies in various pH shows that 2-
phenoxypyrimidine (41) and 2-(3-methoxyphenoxy)pyrimidine (43)  fluoresced at 
lower intensity in acid condition and fluoresced at higher intensity in neutral and basic 
condition.   
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CHAPTER 5:  EXPERIMENTAL PROCEDURES 
5.1  Introduction to experimental 
 
 All solvents used are AR Gred and were redistilled before use. Formation of 
compounds was routinely checked by Thin Layer Chromatography (TLC) on 
aluminium sheets, silica gel 60 F254. Melting points were determined in an open capilary 
tube with electrothermal Melting point Apparatus and were not corrected. 
 
 Infrared spectra were recorded using Perkin Elmer 298 Infrared Spectrometer 
and FTIR Perkin Elmer 1600 Series in KBr for solid compounds and neat for liquid 
compounds. 
 
 The 1H and 13C NMR spectra were recorded in CDCl3 on JEOL FT-NMR 
Lambda 400MHz and FT-NMR ECA 400 MHz spectrometer. Mass spectra were 
recorded with GC-MS Hewlett-Packard HP 6890 series with mass selective indicator 
and GCMS QP5050A Shimadzu. 
 
 Fluorescence spectra were recorded by Luminescence Spectrophotometer Perkin 
Elmer Model LS 50B and quartz cell were used. All starting materials were obtained 
from Sigma-Aldrich and Merck. 
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5.2      Preparation of pyrimidine and pyrazine derivatives 
5.2.1    Pyrimidine derivatives 
5.2.1.1 Preparation of 2-(2-methoxyphenoxy)pyrimidine (37)  
  
 
o-Methoxyphenol (36) (2.3 mL, 0.02 moles) was added to sodium hydroxide pellet (0.8 
g, 0.02 moles) in minimum volume of water (5 mL). The mixture was heated until a dry 
solid was formed. 2-Chloropyrimidine (35) (2.28 g, 0.02 moles) in THF (5mL) was then 
added to the dry white solid and refluxed for 5 hours. The mixture was cooled to room 
temperature and the solvent was removed. Water (10 mL) was added to the reaction 
mixture followed by extraction with chloroform (3 x 10 mL). The organic layer was 
washed twice with water (2 x 10 mL) and dried over anhydrous sodium sulphate. 
Filtration, evaporation of the organic layer and purification of the residue using 
chloroform gave the product.  
M.p. 120-122 °C, (2.4 g, 60 %), IR (νmax, cm-1): 1569 (C=N), 1498 and 1404 (aromatic 
C=C), 1302 and 1023 (C-O); 1H NMR  δH: 8.54 (2H, d, J= 4.88 Hz, H-6, H-4),  7.22 
(2H, m, H-5), 
 
7.01 (3H, m, H-3’, H-4’, H-5’, H-6’), 
 
3.74 (3H, s, CH3); 13C NMR  δC : 
165.2 (C-2), 159.5 (C-4, C-6), 151.5 (C-1’), 141.8 (C-2’), 126.5 (C-5), 122.7 (C-3’), 
121.0 (C-4’), 115.9 (C-5’), 112.7 (C-6’), 55.8 (OCH3); MS: M+ found =202.00; 
C11H10N2O2 requires M+ = 202.07.    
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5.2.1.2  Preparation of 2-(p-methoxyphenoxy)pyrimidine 
(39) 
 
p-Methoxyphenol (38) (1.49 g, 0.012 moles) was added to sodium hydroxide pellet 
(0.67 g, 0.012 moles) in minimum volume of water (5 mL). The mixture was heated 
until a dry solid was formed. 2-Chloropyrimidine (35) (1.37 g, 0.012 moles) in THF 
(5mL) was then added to the dry white solid and refluxed for 5 hours. The mixture was 
cooled to room temperature and the solvent was removed. Water (10 mL) and 5% 
sodium hydroxide solution (5 mL) was added to the reaction mixture followed by 
extraction with chloroform (3 x 10 mL). The organic layer was washed twice with water 
(2 x 10 mL) and dried over anhydrous sodium sulphate. Filtration and evaporation of 
chloroform and recrystallization gave the product.  
M.p. 50-52 °C, (1.2 g, 50 %), IR (νmax, cm-1): 1568 (C=N), 1509 and 1404 (aromatic 
C=C), 1308 and 1030 (C-O); 1H-NMR δH: 8.56 (2H, d, J= 4.64 Hz, H-4, H-6), 7.14 (2H, 
d, J= 9.28, H-2’, H-6’), 7.01 (2H, t, J= 4.88, H-5), 6.96 (2H, d, J=9.28, H-3’, H-5’); 13C 
NMR δC C: 165.8 (C-2), 159.7 (C-4, C-6), 157.0 (C-1’), 146.3 (C-4’), 122.5 (C-5), 
116.0 (C-6’, C-2’), 114.7 (C-5’, C-3’), 55.6 (OCH3); MS: M+ found =202.00; 
C11H10N2O2 requires M+ = 202.07.    
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5.2.1.3  Preparation of 2-phenoxypyrimidine (41) 
 
Phenol (40) (1.04 mL, 0.0096 moles) was added to sodium hydroxide pellet (0.384 g, 
0.0096 moles) in minimum volume of water (5 mL). The mixture was heated until a dry 
solid was formed. 2-Chloropyrimidine (35) (1.49 g, 0.0096 moles) in THF (5mL) was 
then added to the dry white solid and refluxed for 5 hours. The mixture was cooled to 
room temperature and the solvent was removed. Water (10 mL) was added to the 
reaction mixture followed by extraction with chloroform (3 x 10 mL). The organic layer 
was washed twice with water (2 x 10 mL) and dried over anhydrous sodium sulphate. 
Filtration and evaporation of chloroform gave the product.  
M.p. 88-99 °C, (0.8 g, 50 %), IR (νmax, cm-1): 1576 (C=N), 1492 and 1404 (aromatic 
C=C), 1302 and 1023 (C-O); 1H NMR δH: 8.55 (2H, d, J= 4.88 Hz, H-4, H-6), 7.42 (2H, 
t, J= 6.6 Hz, H-3’, H-5’), 
 
7.23 (2H, d, J= 5.84 Hz, H-2’, H-6’), 
 
7.18 (1H, d, J= 7.6 Hz, 
H-4’), 7.01 (1H, t, J= 4.88 Hz, H-5); 13C NMR 
 
δC :165.4 (C-2), 159.7 (C-4, C-6), 152.8 
(C-1’), 129.6 (C-5), 125.5 (C-2’, C-6’), 121.6 (C-3’, C-5’), 116.1 (C-4’); MS: M+ found 
=172.00; C10H8N2O requires M+ = 172.06.    
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5.2.1.4  Preparation of 2-(3-methoxyphenoxy)pyrimidine 
(43) 
 
 m-Methoxyphenol (37) (2.2 mL, 0.02 moles) was added to sodium hydroxide pellet 
(0.8 g, 0.02 moles) in minimum volume of water (5 mL). The mixture was heated until 
a dry solid was formed. 2-Chloropyrimidine (35) (1.8 g, 0.02 moles) in THF (5mL) was 
then added to the dry white solid and refluxed for 5 hours. The mixture was cooled to 
room temperature and the solvent was removed. Water (10 mL) was added to the 
reaction mixture followed by extraction with chloroform (3 x 10 mL). The organic layer 
was washed twice with water (2 x 10 mL) and dried over anhydrous sodium sulphate. 
Filtration and evaporation of chloroform and purification gave the product.  
M.p. 78-80 °C, (1.45 g, 36 %), IR (νmax, cm-1): 1571 (C=N), 1483 and 1398 (aromatic 
C=C), 1279 and 1035 (C-O); 1H NMR δH: 8.57 (2H, d, J= 4.64 Hz, H-4, H-6),  7.33 
(1H, t, J= 8.28 Hz, H-5), 
 
7.04 (1H, t, J= 4.64 Hz, H-2’), 
 
6.78 (3H, m, , H-4’, H-5’, H-
6’), 3.81 (3H, s, -OCH3); 13C NMR δC : 165.3 (C-2), 160.7 (C-1’), 159.7 (C-3’), 153.9 
(C-4), 130.0 (C-6), 116.2 (C-5), 113.8 (C-2’), 111.3 (C-4’), 107.7 (C-5’), 100.5 (C-6’), 
55.4 (CH3); MS: M+ found =202.00; C11H10N2O2 requires M+ = 202.07.    
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5.2.1.5  Preparation of 2-(o-tolyloxy)pyrimidine (45) 
 
o-Cresol (44) (2.16 mL, 0.02 moles) was added to sodium hydroxide pellet (0.8 g, 0.02 
moles) in minimum volume of water (5 mL). The mixture was heated until a dry solid 
was formed. 2-Chloropyrimidine (35) (2.28 g, 0.02 moles) in THF (5mL) was then 
added to the dry white solid and refluxed for 5 hours. The mixture was cooled to room 
temperature and the solvent was removed. Water (10 mL) was added to the reaction 
mixture followed by extraction with chloroform (3 x 10 mL). The organic layer was 
washed twice with water (2 x 10 mL) and dried over anhydrous sodium sulphate. 
Filtration and evaporation of chloroform gave the product.  
M.p. 77-78 °C, (1.5 g, 40 %), IR (νmax, cm-1): 1572 (C=N), 1489 and 1400 (aromatic 
C=C), 1303 and 1041 (C-O); 1H NMR δH: 8.56 (2H, d, J= 4.88 Hz, C(4)-H, C(6)-H),  
7.30 (2H, t, J= 7.32 Hz, C(3’)-H, C(6’)-H), 
 
7.19 (1H, t, J= 6.12 Hz, C(4’)-H), 
 
7.12 
(1H, d, 7.80, C(5’)-H), 7.01 (1H, t, J= 4.64 Hz, C(5)-H);  13C NMR δC :165.1 (C-2), 
159.7 (C-4/C-6), 151.3 (C-1’), 131.3 (C-2’), 130.9 (C-3’), 127.1 (C-5’), 125.8 (C-4’), 
121.8 (C-6’), 115.8 (C-5), 16.2 (-CH3); MS: M+ found =186.00; C11H10N2O requires M+ 
= 186.08.    
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5.2.1.6  Preparation of 2-(pyrimidin-2-yloxy)phenol (47) 
 
1, 2-Dihydroxybenzene (46) (12 g, 0.108 moles) was added to sodium hydroxide pellet 
(0.384 g, 0.04 moles) in minimum volume of water (5 mL). The mixture was heated 
until a dry solid was formed. 2-Chloropyrimidine (35) (2 g, 0.018 moles) in THF (5mL) 
was then added to the dry white solid and refluxed for 5 hours. The mixture was cooled 
to room temperature and the solvent was removed. Water (10 mL) was added to the 
reaction mixture followed by extraction with chloroform (3 x 10 mL). The organic layer 
was washed twice with water (2 x 10 mL) and dried over anhydrous sodium sulphate. 
Filtration and evaporation of chloroform gave the product.  
M.p. 165-167 °C, (0.84 g, 25 %), IR (νmax, cm-1): 3297 (OH), 1575 (C=N), 1492 and 
1409 (aromatic C=C), 1285 and 1223 (C-O); 1H NMR δH: 9.55 (1H, s, O-H),  8.58 (2H, 
d, J= 5.36 Hz, H-4, H-6), 
 
7.19 (1H, t, J= 4.16 Hz, H-5), 
 
7.05 (2H, t, J= 7.06 Hz,, H-3’, 
H-6’), 6.92 (1H, t, J= 6.32 Hz, H-4’), 6.80 (1H, t, J=5.88 Hz, H-5’); 13C NMR δC : 164.8 
(C-2), 160.0 (C-1’, C-2’), 149.4 (C-4), 140.8 (C-6), 126.3 (C-5), 123.1 (C-3’),  119.6 
(C-4’), 117.1 (C-5’), 116.7 (C-6’) ; MS: M+ found =188.00; C10H8N2O2 requires M+ = 
188.06.    
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5.2.1.7  Preparation of 2-(3-nitrophenoxy)pyrimidine (49) 
 
m-Nitrophenol (48) (1.04 ml, 0.0096 moles) was added to sodium hydroxide pellet 
(0.384 g, 0.0096 moles) in minimum volume of water (5 mL). The mixture was heated 
until a dry solid was formed. 2-Chloropyrimidine (35) (1.49 g, 0.0096 moles) in THF 
(5mL) was then added to the dry white solid and refluxed for 5 hours. The mixture was 
cooled to room temperature and the solvent was removed. Water (10 mL) was added to 
the reaction mixture followed by extraction with chloroform (3 x 10 mL). The organic 
layer was washed twice with water (2 x 10 mL) and dried over anhydrous sodium 
sulphate. Filtration, evaporation of chloroform and recrystallization gave the product.  
M.p. 100-103 °C, (0.8 g, 39 %), IR (νmax, cm-1): 1578 (C=N), 1525 and 1400 (aromatic 
C=C), 1353 (N=O), 1300 and 1075 (C-O); 1H NMR δH: 8.54 (2H,  d, J= 4.88 Hz, H-4, 
H-6), 8.05
 
(2H, m, H-2’, H-4’), 
 
7.55 (2H, m, H-5’, H-6’), 
 
7.07 (1H, t, J= 4.88 Hz, H-
5); 13C NMR δC : 164.6 (C-2), 159.9 (C-4, C-5, C-6) 153.0 (C-1’), 130.2 (C-3’), 128.1 
(C-2’), 120.3 (C-5’), 117.4 (C-6’), 117.1 (C-4’); MS: M+ found =217.00 ; C10H7N3O3 
requires M+ = 217.05.    
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5.2.1.8  Preparation of 2-(p-tolyloxy)pyrimidine (51) 
 
p-Cresol (50) (2.00 mL, 0.02 moles) was added to sodium hydroxide pellet (0.8 g, 0.02 
moles) in minimum volume of water (5 mL). The mixture was heated until a dry solid 
was formed. 2-Chloropyrimidine (35) (2.28 g, 0.02 moles) in THF (5mL) was then 
added to the dry white solid and refluxed for 5 hours. The mixture was cooled to room 
temperature and the solvent was removed. Water (10 mL) was added to the reaction 
mixture followed by extraction with chloroform (3 x 10 mL). The organic layer was 
washed twice with water (2 x 10 mL) and dried over anhydrous sodium sulphate. 
Filtration and evaporation of chloroform gave the product.  
M.p. 65-68 °C, (1.2 g, 33 %), IR (νmax, cm-1): 1576 (C=N), 1509 and 1414 (aromatic 
C=C), 1300 and 1022 (C-O); 1H NMR δH: 8.58 (2H, d, J= 4.88 Hz, H-4, H-6),  7.28 
(2H, d, J= 8.76 Hz, H-2’,H-6’), 
 
7.12 (2H, d, J= 8.56 Hz, H-3’, H-5’), 
 
7.03 (1H, t, J= 
4.64 Hz, H-5); 13C NMR δC : 165.6 (C-2), 159.7 (C-4, C-6), 150.6 (C-1’), 135.1 (C-4’), 
130.2 (C-2’, C-6’), 121.3 (C-3’, C-4’), 115.9 (C-5), 20.9 (CH3); MS: M+ found =186.00; 
C11H10N2O requires M+ = 186.00    
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5.2.1.9  Preparation of 2-phenoxypyrimidin-4-amine (53) 
 
Phenol (40) (0.94 mL, 0.01 moles) was added to sodium hydroxide pellet (0.4 g, 0.01 
moles) in minimum volume of water (5 mL). The mixture was heated until a dry solid 
was formed. 4-amino-2-chloropyrimidine (1.6 g, 0.01 moles) in THF (5mL) was then 
added to the dry white solid and refluxed for 5 hours. The mixture was cooled to room 
temperature and the solvent was removed. Water (10 mL) was added to the reaction 
mixture followed by extraction with chloroform (3 x 10 mL). The organic layer was 
washed twice with water (2 x 10 mL) and dried over anhydrous sodium sulphate. 
Filtration and evaporation of chloroform gave the product. Recrystallization gave pure 
product.  
M.p. 131-134 °C, (0.88 g, 47 %), IR (νmax, cm-1): 3130 (NH2), 1590 (C=N), 1482 and 
1375 (aromatic C=C), 1294 and 1022 (C-O); 1H-NMR δH: 8.02 (1H, d, J= 5.64 Hz, H-
6), 7.38 (2H, t, J= 8.28 Hz, H-3’, H-5’), 
 
7.17 (3H, m, H-2’, H-4’, H-6’), 
 
6.14 (1H, d, J= 
5.64 Hz, H-5), 4.95 (2H, s, -NH2); 13C NMR  δC : 165.4 (C-2), 165.0 (C-4), 157.8 (C-6), 
153.0 (C-1’), 129.6 (C-5), 129.4 (C-2’), 125.0 (C-3’), 121.8 (C-4’), 115.3 (C-5’), 100.3 
(C-6’); GCMS: M+ found =187.00; C10H9N3O requires M+ = 187.07.    
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5.2.2  Pyrazine derivatives 
5.2.2.1 Preparation of 2-(2-methoxyphenoxy)pyrazine (55) 
 
o-Methoxyphenol (36) (5.6 mL, 0.045 moles) was added to potassium hydroxide pellet 
(2.5 g, 0.045 moles) in minimum volume of water (5 mL). The mixture was heated until 
a dry solid was formed. 2-Chloropyrazine (52) (4 mL, 0.045 moles) in THF (5mL) was 
then added to the dry white solid and refluxed for 5 hours. The mixture was cooled to 
room temperature and the solvent was removed. Water (10 mL) and was added to the 
reaction mixture followed by extraction with chloroform (3 x 10 mL). The organic layer 
was washed twice with water (2 x 10 mL) and dried over anhydrous sodium sulphate. 
Filtration and evaporation of chloroform gave the product.  
M.p. 79-80 °C, (3.7 g, 41 %), IR (νmax, cm-1): 1580 (C=N), 1500 and 1405 (aromatic 
C=C), 1279 and 1007 (C-O); 1H NMR δH: 8.43 (1H, s, H-3),  8.22 (1H, s, H-5),  8.06 
(1H, s, H-6), 7.23
 
(1H, d, J= 8.08 Hz, H-6’), 7.16 (1H, d, J= 6.6 Hz, H-2’), 7.03 (2H, t, 
J= 8.28 Hz, H-3’, H-4’); 13C NMR 
 
δC : 160.1 (C-2), 151.5 (C-1’), 141.5 (C-2’), 141.0 
(C-3), 138.1 (C-5), 135.2 (C-6), 126.7 (C-4’), 122.9 (C-6’), 121.1 (C-5’), 112.8 (C-3’), 
55.7 (-OCH3) ; MS: M+ found =202.00; C11H10N2O2 requires M+ = 202.07.    
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5.2.2.2  Preparation of 2-(4-methoxyphenoxy)pyrazine (56) 
 
p-Methoxyphenol (38) (5.6 g, 0.045 moles) was added to potassium hydroxide pellet 
(2.5 g, 0.045 moles) in minimum volume of water (5 mL). The mixture was heated until 
a dry solid was formed. 2-chloropyrazine (52) (4 mL, 0.045 moles) in THF (5mL) was 
then added to the dry white solid and refluxed for 5 hours. The mixture was cooled to 
room temperature and the solvent was removed under vacuo. Water (10 mL) was added 
to the reaction mixture followed by extraction with chloroform (3 x 10 mL). The 
organic layer was washed twice with water (2 x 10 mL) and dried over anhydrous 
sodium sulphate. Filtration and evaporation of chloroform gave the product.  
M.p. 80-82 °C, (3.8 g, 42 %), IR (νmax, cm-1): 1584 (C=N), 1506 and 1408 (aromatic 
C=C), 1288 and 1005 (C-O); 1H NMR δH: 8.40 (1H, s, H-5),  8.23 (1H, d, J= 2.68 Hz, 
H-6), 8.09 (1H, dd, J= 1.48 Hz, H-3), 
 
7.10 (2H, d, J= 10.48 Hz, H-2’, H-6’), 6.97 (2H, 
d, J= 6.8 Hz, H-3’, H-5’); 13C NMR 
 
δC : 160.6 (C-2), 157.0 (C-1’), 146.2 (C-4’), 141.0 
(C-3), 138.1 (C-5), 135.7 (C-6), 122.3 (C-6’, C-2’), 114.8 (C-5’, C-3’), 55.6 (CH3); MS: 
M+ found =202.00; C11H10N2O2 requires M+ = 202.07.    
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5.3   Fluorescence Measurements 
All solvents (ethanol, tetrahydrofuran, ethyl acetate, hexane and acetonitrile) 
were purged with nitrogen gas before use. 
 
5.3.1 Fluorescence measurement of pyrimidine and pyrazine 
derivatives 
 
The fluorescence spectra of all the compounds studied were measured in various 
solvents. Samples were prepared from stock solution (10-4 M) of the corresponding 
compound in tetrahydrofuran (THF), acetonitrile (CH3CN), ethyl acetate (EtOAc), 
ethanol (EtOH) and hexane  to give concentrations of 10-5 M and 10-6 M 
 
 2-(2-Methoxyphenoxy)pyrimidine (37), 
 
2-(2-Methoxyphenoxy)pyrimidine (37) (1.0 mg) was dissolved in solvents (10 ml) 
Concentration = 4.9505 X 10m M, where 10m= 10-4, 10-5 and 10-6 
Excitation and emission slits = 5 
Fluorescence 
10-4 M 10-5 M 10-6M 
 
Compound 
 
Excitation 
Emission Intensity Emission Intensity Emission Intensity 
Hexane 326 358 79.94 X X X X 
Ethanol 260 312 43.99 X X X X 
Acetonitrile 201 355 50.97 347 48.25 X X 
Ethyl acetate 210 329 6.51 X X X X 
THF 203 389 41.57 X X X X 
X = non-fluorescent 
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2-(4-Methoxyphenoxy)pyrimidine (39) 
 
2-(4-Methoxyphenoxy)pyrimidine (39) (1.0 mg) was dissolved in solvents (10 mL) 
Concentration = 4.9505 X 10m M, where 10m= 10-4, 10-5 and 10-6 
Excitation and emission slits = 5 
Fluorescence 
10-4 M 10-5 M 10-6M 
 
Compound 
 
Excitation 
Emission Intensity Emission Intensity Emission Intensity 
Hexane 350 380 95.38 X X X X 
Ethanol 201 388 61.91 381 35.00 X X 
Acetonitrile 203 323 469.05 318 213.77 313 69.30 
Ethyl acetate 204 392 130.11 384 41.31 X X 
THF 207 380 149.08 X X X X 
X = non-fluorescent 
 
 
 2-Phenoxypyrimidine (41) 
 
2-Phenoxypyrimidine (41) (1.0 mg) was dissolved in solvents (10 mL) 
Concentration = 5.814 X 10m M, where 10m= 10-4, 10-5 and 10-6 
Excitation and emission slits = 5 
Fluorescence 
10-4 M 10-5 M 10-6M 
 
Compound 
 
Excitation 
Emission Intensity Emission Intensity Emission Intensity 
hexane 340 366 75.41 X X X X 
ethanol 201 381 16.61 374 31.66 358 67.07 
acetonitrile 205 370 53.75 362 35.07 354 30.88 
Ethyl acetate 201 362 59.53 362 32.29 375 11.68 
THF 345 369 111.00 353 77.07 X X 
X = non-fluorescent 
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2-(3-Methoxyphenoxy)pyrimidine (43) 
 
2-(3-Methoxyphenoxy)pyrimidine (43) (1.0 mg) was dissolved in solvents (10 mL) 
Concentration = 4.9505 X 10m M, where 10m= 10-4, 10-5 and 10-6 
Excitation and emission slits = 5 
Fluorescence 
10-4 M 10-5 M 10-6M 
 
Compound 
 
Excitation 
Emission Intensity Emission Intensity Emission Intensity 
Hexane 201 359 59.55 356 67.22 X X 
Ethanol 213 379 15.04 373 8.06 X X 
Acetonitrile 204 364 10.39 385 12.29 374 20.80 
Ethyl acetate 209 349 28.84 X X X X 
THF 202 344 61.83 372 68.62 X X 
X = non-fluorescent 
 
 
2-(o-Tolyloxy)pyrimidine (45) 
 
2-(o-Tolyloxy)pyrimidine (45) (1.0 mg) was dissolved in solvents (10 mL) 
Concentration = 5.3763 X 10m M, where 10m= 10-4, 10-5 and 10-6 
Excitation and emission slits = 5 
Fluorescence 
10-4 M 10-5 M 10-6M 
 
Compound 
 
Excitation 
Emission Intensity Emission Intensity Emission Intensity 
Hexane 324 362 66.52 355 69.08 X X 
Ethanol 207 354 9.79 361 44.37 X X 
Acetonitrile 205 389 15.88 378 45.16 375 39.36 
Ethyl acetate 210 351 13.51 X X X X 
THF 202 330 122.01 X X X X 
X = non-fluorescent 
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 2-(Pyrimidin-2-yloxy)phenol (47) 
 
2-(pyrimidin-2-yloxy)phenol (47) (1.0 mg) was dissolved in solvents (10 mL) 
Concentration = 5.3191 X 10m M, where 10m= 10-4, 10-5 and 10-6 
Excitation and emission slits = 5 
Fluorescence 
10-4 M 10-5 M 10-6M 
 
Compound 
 
Excitation 
Emission Intensity Emission Intensity Emission Intensity 
Hexane 201 360 91.63 349 162.78 X X 
Ethanol 200 352 24.42 X X X X 
Acetonitrile 202 356 91.73 356 25.14 X X 
Ethyl acetate 201 377 182.77 381 43.37 X X 
THF 208 348 69.30 353 34.43 367 17.53 
X = non-fluorescent 
 
 
 2-(3-Nitrophenoxy)pyrimidine (49) 
 
2-(3-nitrophenoxy)pyrimidine (49) (1.0 mg) was dissolved in solvents (10 mL) 
Concentration = 4.6083 X 10m M, where 10m = 10-4, 10-5 and 10-6 
Excitation and emission slits = 5 
Fluorescence 
10-4 M 10-5 M 10-6M 
 
Compound 
 
Excitation 
Emission Intensity Emission Intensity Emission Intensity 
Hexane 205 382 6.34 X X X X 
Ethanol 382 398 8.72 X X X X 
Acetonitrile X X X X X X X 
Ethyl acetate 208 352 5.73 X X X X 
THF 205 404 25.41 363 66.27 X X 
X = non-fluorescent 
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2-(p-Tolyloxy)pyrimidine (51) 
 
2-(p-Tolyloxy)pyrimidine (51) (1.0 mg) was dissolved in solvents (10 mL) 
Concentration = 5.3763 X 10m M, where 10m= 10-4, 10-5 and 10-6 
Excitation and emission slits = 5 
Fluorescence 
10-4 M 10-5 M 10-6M 
 
Compound 
 
Excitation 
Emission Intensity Emission Intensity Emission Intensity 
Hexane 207 372 64.70 375 120.76 X X 
Ethanol 213 374 3.92 362 9.31 X X 
Acetonitrile 204 366 29.67 364 36.92 X X 
Ethyl acetate 200 358 35.31 373 11.95 X X 
THF 207 344 101.95 346 121.11 X X 
X = non-fluorescent 
 
 
2-Phenoxypyrimidin-4-amine (53) 
 
2-Phenoxypyrimidin-4-amine (53) (1.0 mg) was dissolved in solvents (10 mL) 
Concentration = 5.3476 X 10m M, where 10m= 10-4, 10-5 and 10-6 
Excitation and emission slits = 5 
Fluorescence 
10-4 M 10-5 M 10-6M 
 
Compound 
 
Excitation 
Emission Intensity Emission Intensity Emission Intensity 
Hexane 203 358 274.44 374 97.48 X X 
Ethanol 328 360 916.56 364 347.01 362 87.28 
Acetonitrile 212 372 431.18 358 145.44 X X 
Ethyl acetate 204 324 830.94 X X X X 
THF 226 332 274.35 339 44.80 X X 
X = non-fluorescent 
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 2-(2-Methoxyphenoxy)pyrazine (55) 
 
2-(2-Methoxyphenoxy)pyrazine (55) (1.0 mg) was dissolved in solvents (10 mL) 
Concentration = 4.9505 X 10m M, where 10m= 10-4, 10-5 and 10-6 
Excitation and emission slits = 5 
Fluorescence 
10-4 M 10-5 M 10-6M 
 
Compound 
 
Excitation 
Emission Iintensity Emission Intensity Emission Intensity 
Hexane 345 355 215.63 351 78.88 X X 
Ethanol 214 359 2.70 372 11.72 X X 
Acetonitrile 203 361 49.61 362 53.60 X X 
Ethyl acetate 344 437 130.55 439 28.63 X X 
THF 203 381 18.78 367 35.86 X X 
X = non-fluorescent 
 
 
2-(4-Methoxyphenoxy)pyrazine (56) 
 
2-(4-Methoxyphenoxy)pyrazine (56) (1.0 mg) was dissolved in solvents (10 mL) 
Concentration = 4.9505 X 10m M, where 10m= 10-4, 10-5 and 10-6 
Excitation and emission slits = 5 
Fluorescence 
10-4 M 10-5 M 10-6M 
 
Compound 
 
Excitation 
Emission Intensity Emission Intensity Emission Intensity 
Hexane 349 377 283.47 380 111.98 383 50.04 
Ethanol 200 377 12.15 354 22.52 X X 
Acetonitrile 201 379 31.65 350 40.78 369 98.13 
Ethyl acetate 347 446 100.07 445 25.07 X X 
THF 204 401 37.68 399 29.14 X X 
X = non-fluorescent 
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